{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:57:32Z","timestamp":1790639852376,"version":"4.1.0"},"reference-count":379,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"DOI":"10.1007\/s00125-026-06853-9","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T10:29:57Z","timestamp":1790591397000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Insulin resistance in the 21st century: new takes on an old problem\u20142025 Diabetes, Diabetes Care, and Diabetologia Expert Forum"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2594-1651","authenticated-orcid":false,"given":"Amalia","family":"Gastaldelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3286-6477","authenticated-orcid":false,"given":"Eunhee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Conde-Knape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7209-8022","authenticated-orcid":false,"given":"Olga","family":"G\u00f6ransson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0891-0258","authenticated-orcid":false,"given":"Anna","family":"Krook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4189-2415","authenticated-orcid":false,"given":"Sanna","family":"Lehtonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8200-6382","authenticated-orcid":false,"given":"Michael","family":"Roden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0973-847X","authenticated-orcid":false,"given":"Patrick","family":"Schrauwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8724-6016","authenticated-orcid":false,"given":"Lauren M.","family":"Sparks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8462-3832","authenticated-orcid":false,"given":"Martin","family":"Heni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"6853_CR1","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1172\/JCI89444","volume":"127","author":"E \u00c1lvarez Hern\u00e1ndez","year":"2017","unstructured":"\u00c1lvarez Hern\u00e1ndez E, Kahl S, Seelig A et al (2017) Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance. J Clin Invest 127:695\u2013708. https:\/\/doi.org\/10.1172\/JCI89444","journal-title":"J Clin Invest"},{"key":"6853_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1042\/bse0420031","volume":"42","author":"JFP Wojtaszewski","year":"2006","unstructured":"Wojtaszewski JFP, Richter EA (2006) Effects of acute exercise and training on insulin action and sensitivity: focus on molecular mechanisms in muscle. Essays Biochem 42:31\u201346. https:\/\/doi.org\/10.1042\/bse0420031","journal-title":"Essays Biochem"},{"key":"6853_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41574-018-0122-1","volume":"15","author":"DJ Stenvers","year":"2019","unstructured":"Stenvers DJ, Scheer FAJL, Schrauwen P, La Fleur SE, Kalsbeek A (2019) Circadian clocks and insulin resistance. Nat Rev Endocrinol 15:75\u201389. https:\/\/doi.org\/10.1038\/s41574-018-0122-1","journal-title":"Nat Rev Endocrinol"},{"key":"6853_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41574-023-00898-1","volume":"20","author":"G Xourafa","year":"2024","unstructured":"Xourafa G, Korbmacher M, Roden M (2024) Inter-organ crosstalk during development and progression of type 2 diabetes mellitus. Nat Rev Endocrinol 20:27\u201349. https:\/\/doi.org\/10.1038\/s41574-023-00898-1","journal-title":"Nat Rev Endocrinol"},{"key":"6853_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11886-016-0755-4","volume":"18","author":"AE Brown","year":"2016","unstructured":"Brown AE, Walker M (2016) Genetics of insulin resistance and the metabolic syndrome. Curr Cardiol Rep 18:75. https:\/\/doi.org\/10.1007\/s11886-016-0755-4","journal-title":"Curr Cardiol Rep"},{"key":"6853_CR6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/joim.12547","volume":"280","author":"ED Rosen","year":"2016","unstructured":"Rosen ED (2016) Epigenomic and transcriptional control of insulin resistance. J Intern Med 280:443\u2013456. https:\/\/doi.org\/10.1111\/joim.12547","journal-title":"J Intern Med"},{"key":"6853_CR7","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1152\/physrev.00002.2020","volume":"101","author":"DJ Hoffman","year":"2021","unstructured":"Hoffman DJ, Powell TL, Barrett ES, Hardy DB (2021) Developmental origins of metabolic diseases. Physiol Rev 101:739\u2013795. https:\/\/doi.org\/10.1152\/physrev.00002.2020","journal-title":"Physiol Rev"},{"key":"6853_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/9780470513095.ch4","volume-title":"Clinical diabetes research: methods and techniques","author":"A Brehm","year":"2007","unstructured":"Brehm A, Roden M (2007) Glucose clamp techniques. In: Roden M (ed) Clinical diabetes research: methods and techniques. John Wiley, Chichester, UK, pp 43\u201376"},{"key":"6853_CR9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2337\/diab.34.3.222","volume":"34","author":"WT Garvey","year":"1985","unstructured":"Garvey WT, Olefsky JM, Griffin J, Hamman RF, Kolterman OG (1985) The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 34:222\u2013234. https:\/\/doi.org\/10.2337\/diab.34.3.222","journal-title":"Diabetes"},{"key":"6853_CR10","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.2337\/diabetes.53.12.3048","volume":"53","author":"M Krssak","year":"2004","unstructured":"Krssak M, Brehm A, Bernroider E et al (2004) Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes. Diabetes 53:3048\u20133056. https:\/\/doi.org\/10.2337\/diabetes.53.12.3048","journal-title":"Diabetes"},{"key":"6853_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1210\/endrev\/bnae032","volume":"46","author":"M Apostolopoulou","year":"2025","unstructured":"Apostolopoulou M, Lambadiari V, Roden M, Dimitriadis GD (2025) Insulin resistance in type 1 diabetes: pathophysiological, clinical, and therapeutic relevance. Endocr Rev 46:317\u2013348. https:\/\/doi.org\/10.1210\/endrev\/bnae032","journal-title":"Endocr Rev"},{"key":"6853_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1172\/JCI114142","volume":"84","author":"LC Groop","year":"1989","unstructured":"Groop LC, Bonadonna RC, DelPrato S et al (1989) Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus: evidence for multiple sites of insulin resistance. J Clin Invest 84:205\u2013213. https:\/\/doi.org\/10.1172\/JCI114142","journal-title":"J Clin Invest"},{"key":"6853_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2021.12.012","volume":"34","author":"S Klein","year":"2022","unstructured":"Klein S, Gastaldelli A, Yki-Jarvinen H, Scherer PE (2022) Why does obesity cause diabetes? Cell Metab 34:11\u201320. https:\/\/doi.org\/10.1016\/j.cmet.2021.12.012","journal-title":"Cell Metab"},{"key":"6853_CR14","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.cmet.2021.03.019","volume":"33","author":"A Santoro","year":"2021","unstructured":"Santoro A, McGraw TE, Kahn BB (2021) Insulin action in adipocytes, adipose remodeling, and systemic effects. Cell Metab 33:748\u2013757. https:\/\/doi.org\/10.1016\/j.cmet.2021.03.019","journal-title":"Cell Metab"},{"key":"6853_CR15","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.cmet.2021.03.020","volume":"33","author":"L Sylow","year":"2021","unstructured":"Sylow L, Tokarz VL, Richter EA, Klip A (2021) The many actions of insulin in skeletal muscle, the paramount tissue determining glycemia. Cell Metab 33:758\u2013780. https:\/\/doi.org\/10.1016\/j.cmet.2021.03.020","journal-title":"Cell Metab"},{"key":"6853_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41575-023-00888-8","volume":"21","author":"E Scoditti","year":"2024","unstructured":"Scoditti E, Sabatini S, Carli F, Gastaldelli A (2024) Hepatic glucose metabolism in the steatotic liver. Nat Rev Gastroenterol Hepatol 21:319\u2013334. https:\/\/doi.org\/10.1038\/s41575-023-00888-8","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"6853_CR17","doi-asserted-by":"publisher","first-page":"F1087","DOI":"10.1152\/ajprenal.00340.2016","volume":"311","author":"B Spoto","year":"2016","unstructured":"Spoto B, Pisano A, Zoccali C (2016) Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Renal Physiol 311:F1087\u2013F1108. https:\/\/doi.org\/10.1152\/ajprenal.00340.2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"6853_CR18","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1210\/jcem.83.6.4878","volume":"83","author":"E Muscelli","year":"1998","unstructured":"Muscelli E, Emdin M, Natali A et al (1998) Autonomic and hemodynamic responses to insulin in lean and obese humans. J Clin Endocrinol Metab 83:2084\u20132090. https:\/\/doi.org\/10.1210\/jcem.83.6.4878","journal-title":"J Clin Endocrinol Metab"},{"key":"6853_CR19","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00125-024-06104-9","volume":"67","author":"M Heni","year":"2024","unstructured":"Heni M (2024) The insulin resistant brain: impact on whole-body metabolism and body fat distribution. Diabetologia 67:1181\u20131191. https:\/\/doi.org\/10.1007\/s00125-024-06104-9","journal-title":"Diabetologia"},{"key":"6853_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","volume":"576","author":"M Roden","year":"2019","unstructured":"Roden M, Shulman GI (2019) The integrative biology of type 2 diabetes. Nature 576:51\u201360. https:\/\/doi.org\/10.1038\/s41586-019-1797-8","journal-title":"Nature"},{"key":"6853_CR21","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1152\/physrev.00015.2017","volume":"98","author":"S Gancheva","year":"2018","unstructured":"Gancheva S, Jelenik T, \u00c1lvarez-Hern\u00e1ndez E, Roden M (2018) Interorgan metabolic crosstalk in human insulin resistance. Physiol Rev 98:1371\u20131415. https:\/\/doi.org\/10.1152\/physrev.00015.2017","journal-title":"Physiol Rev"},{"key":"6853_CR22","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1016\/j.cell.2025.05.005","volume":"188","author":"J Kj\u00e6rgaard","year":"2025","unstructured":"Kj\u00e6rgaard J, Stocks B, Henderson J et al (2025) Personalized molecular signatures of insulin resistance and type 2 diabetes. Cell 188:4106-4122.e16. https:\/\/doi.org\/10.1016\/j.cell.2025.05.005","journal-title":"Cell"},{"key":"6853_CR23","doi-asserted-by":"publisher","first-page":"e000143","DOI":"10.1136\/bmjsem-2016-000143","volume":"2","author":"SR Bird","year":"2017","unstructured":"Bird SR, Hawley JA (2017) Update on the effects of physical activity on insulin sensitivity in humans. BMJ Open Sport Exerc Med 2:e000143. https:\/\/doi.org\/10.1136\/bmjsem-2016-000143","journal-title":"BMJ Open Sport Exerc Med"},{"key":"6853_CR24","doi-asserted-by":"publisher","first-page":"e001728","DOI":"10.1136\/bmjdrc-2020-001728","volume":"8","author":"GO Skajaa","year":"2020","unstructured":"Skajaa GO, Fuglsang J, Knorr S, M\u00f8ller N, Ovesen P, Kampmann U (2020) Changes in insulin sensitivity and insulin secretion during pregnancy and post partum in women with gestational diabetes. BMJ Open Diabetes Res Care 8:e001728. https:\/\/doi.org\/10.1136\/bmjdrc-2020-001728","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"Suppl 2","key":"6853_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4158\/EP.9.S2.43","volume":"9","author":"E Ferrannini","year":"2003","unstructured":"Ferrannini E (2003) Analysis of data on insulin resistance from the European Group for the Study of Insulin Resistance: focus on obesity and hypertension. Endocr Pract 9(Suppl 2):43\u201349. https:\/\/doi.org\/10.4158\/EP.9.S2.43","journal-title":"Endocr Pract"},{"key":"6853_CR26","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2337\/db16-1167","volume":"66","author":"A Gastaldelli","year":"2017","unstructured":"Gastaldelli A, Gaggini M, DeFronzo RA (2017) Role of adipose tissue insulin resistance in the natural history of type 2 diabetes: results from the San Antonio Metabolism Study. Diabetes 66:815\u2013822. https:\/\/doi.org\/10.2337\/db16-1167","journal-title":"Diabetes"},{"key":"6853_CR27","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.cmet.2025.12.004","volume":"38","author":"T Marjot","year":"2026","unstructured":"Marjot T, Smith K, Westcott F et al (2026) Human MASLD is a diurnal disease driven by multisystem insulin resistance and reduced insulin availability at night. Cell Metab 38:474-492.e6. https:\/\/doi.org\/10.1016\/j.cmet.2025.12.004","journal-title":"Cell Metab"},{"key":"6853_CR28","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00125-023-05901-y","volume":"66","author":"JM Ratter-Rieck","year":"2023","unstructured":"Ratter-Rieck JM, Roden M, Herder C (2023) Diabetes and climate change: current evidence and implications for people with diabetes, clinicians and policy stakeholders. Diabetologia 66:1003\u20131015. https:\/\/doi.org\/10.1007\/s00125-023-05901-y","journal-title":"Diabetologia"},{"key":"6853_CR29","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s42255-023-00869-w","volume":"5","author":"J Hummel","year":"2023","unstructured":"Hummel J, Benkendorff C, Fritsche L et al (2023) Brain insulin action on peripheral insulin sensitivity in women depends on menstrual cycle phase. Nat Metab 5:1475\u20131482. https:\/\/doi.org\/10.1038\/s42255-023-00869-w","journal-title":"Nat Metab"},{"key":"6853_CR30","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s00125-005-1682-x","volume":"48","author":"E Bugianesi","year":"2005","unstructured":"Bugianesi E, Gastaldelli A, Vanni E et al (2005) Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 48:634\u2013642. https:\/\/doi.org\/10.1007\/s00125-005-1682-x","journal-title":"Diabetologia"},{"key":"6853_CR31","doi-asserted-by":"publisher","first-page":"12977","DOI":"10.1038\/ncomms12977","volume":"7","author":"N Kubota","year":"2016","unstructured":"Kubota N, Kubota T, Kajiwara E et al (2016) Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity. Nat Commun 7:12977. https:\/\/doi.org\/10.1038\/ncomms12977","journal-title":"Nat Commun"},{"key":"6853_CR32","doi-asserted-by":"publisher","first-page":"104949","DOI":"10.1016\/j.isci.2022.104949","volume":"25","author":"P Sen","year":"2022","unstructured":"Sen P, Govaere O, Sinioja T et al (2022) Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease. iScience 25:104949. https:\/\/doi.org\/10.1016\/j.isci.2022.104949","journal-title":"iScience"},{"key":"6853_CR33","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2337\/dc20-1644","volume":"44","author":"KW Ter Horst","year":"2021","unstructured":"Ter Horst KW, Vatner DF, Zhang D et al (2021) Hepatic insulin resistance is not pathway selective in humans with nonalcoholic fatty liver disease. Diabetes Care 44:489\u2013498. https:\/\/doi.org\/10.2337\/dc20-1644","journal-title":"Diabetes Care"},{"key":"6853_CR34","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.cmet.2017.04.015","volume":"25","author":"BH Goodpaster","year":"2017","unstructured":"Goodpaster BH, Sparks LM (2017) Metabolic flexibility in health and disease. Cell Metab 25:1027\u20131036. https:\/\/doi.org\/10.1016\/j.cmet.2017.04.015","journal-title":"Cell Metab"},{"key":"6853_CR35","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1079\/PNS2004349","volume":"63","author":"L Storien","year":"2004","unstructured":"Storien L, Oakes ND, Kelley DE (2004) Metabolic flexibility. Proc Nutr Soc 63:363\u2013368. https:\/\/doi.org\/10.1079\/PNS2004349","journal-title":"Proc Nutr Soc"},{"key":"6853_CR36","doi-asserted-by":"publisher","first-page":"E15","DOI":"10.1152\/ajpendo.00645.2007","volume":"294","author":"R Muniyappa","year":"2008","unstructured":"Muniyappa R, Lee S, Chen H, Quon MJ (2008) Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 294:E15\u2013E26. https:\/\/doi.org\/10.1152\/ajpendo.00645.2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"6853_CR37","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/oby.23503","volume":"30","author":"A Gastaldelli","year":"2022","unstructured":"Gastaldelli A (2022) Measuring and estimating insulin resistance in clinical and research settings. Obesity 30:1549\u20131563. https:\/\/doi.org\/10.1002\/oby.23503","journal-title":"Obesity"},{"key":"6853_CR38","doi-asserted-by":"publisher","unstructured":"Zaharia OP, Strassburger K, Strom A et al; German Diabetes Study Group (2019) Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Lancet Diabetes Endocrinol 7: 684\u2013694 https:\/\/doi.org\/10.1016\/S2213-8587(19)30187-1","DOI":"10.1016\/S2213-8587(19)30187-1"},{"key":"6853_CR39","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419. https:\/\/doi.org\/10.1007\/BF00280883","journal-title":"Diabetologia"},{"key":"6853_CR40","doi-asserted-by":"publisher","first-page":"818","DOI":"10.2337\/diacare.22.5.818","volume":"22","author":"M Emoto","year":"1999","unstructured":"Emoto M, Nishizawa Y, Maekawa K et al (1999) Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 22:818\u2013822. https:\/\/doi.org\/10.2337\/diacare.22.5.818","journal-title":"Diabetes Care"},{"key":"6853_CR41","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2337\/diacare.24.3.539","volume":"24","author":"A Mari","year":"2001","unstructured":"Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539\u2013548. https:\/\/doi.org\/10.2337\/diacare.24.3.539","journal-title":"Diabetes Care"},{"key":"6853_CR42","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462\u20131470. https:\/\/doi.org\/10.2337\/diacare.22.9.1462","journal-title":"Diabetes Care"},{"key":"6853_CR43","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2337\/diacare.23.3.295","volume":"23","author":"M Stumvoll","year":"2000","unstructured":"Stumvoll M, Mitrakou A, Pimenta A et al (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295\u2013301. https:\/\/doi.org\/10.2337\/diacare.23.3.295","journal-title":"Diabetes Care"},{"key":"6853_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00125-003-1263-9","volume":"47","author":"A Gastaldelli","year":"2004","unstructured":"Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA, San Antonio Metabolism Study (2004) Beta-cell dysfunction and glucose intolerance: results from the San Antonio Metabolism (SAM) study. Diabetologia 47:31\u201339. https:\/\/doi.org\/10.1007\/s00125-003-1263-9","journal-title":"Diabetologia"},{"key":"6853_CR45","doi-asserted-by":"publisher","unstructured":"Zaharia O-P, Antoniou S, Bobrov P et al; GDS Group (2023) Reduced insulin clearance differently relates to increased liver lipid content and worse glycemic control in recent-onset type 2 and type 1 diabetes. Diabetes Care 46:2232\u20132239 https:\/\/doi.org\/10.2337\/dc23-1267","DOI":"10.2337\/dc23-1267"},{"key":"6853_CR46","doi-asserted-by":"publisher","first-page":"E214","DOI":"10.1152\/ajpendo.1979.237.3.E214","volume":"237","author":"RA DeFronzo","year":"1979","unstructured":"DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214\u2013E223. https:\/\/doi.org\/10.1152\/ajpendo.1979.237.3.E214","journal-title":"Am J Physiol"},{"key":"6853_CR47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1210\/edrv-6-1-45","volume":"6","author":"RN Bergman","year":"1985","unstructured":"Bergman RN, Finegood DT, Ader M (1985) Assessment of insulin sensitivity in vivo. Endocr Rev 6:45\u201386. https:\/\/doi.org\/10.1210\/edrv-6-1-45","journal-title":"Endocr Rev"},{"key":"6853_CR48","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1007\/s001250051522","volume":"43","author":"A Natali","year":"2000","unstructured":"Natali A, Toschi E, Camastra S, Gastaldelli A, Groop L, Ferrannini E (2000) Determinants of postabsorptive endogenous glucose output in non-diabetic subjects: European Group for the Study of Insulin Resistance (EGIR). Diabetologia 43:1266\u20131272. https:\/\/doi.org\/10.1007\/s001250051522","journal-title":"Diabetologia"},{"key":"6853_CR49","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s00125-005-1683-9","volume":"48","author":"A Mari","year":"2005","unstructured":"Mari A, Pacini G, Brazzale AR, Ahr\u00e9n B (2005) Comparative evaluation of simple insulin sensitivity methods based on the oral glucose tolerance test. Diabetologia 48:748\u2013751. https:\/\/doi.org\/10.1007\/s00125-005-1683-9","journal-title":"Diabetologia"},{"key":"6853_CR50","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s00125-014-3285-x","volume":"57","author":"J Otten","year":"2014","unstructured":"Otten J, Ahr\u00e9n B, Olsson T (2014) Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis. Diabetologia 57:1781\u20131788. https:\/\/doi.org\/10.1007\/s00125-014-3285-x","journal-title":"Diabetologia"},{"key":"6853_CR51","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00592-016-0930-5","volume":"53","author":"R Wagner","year":"2016","unstructured":"Wagner R, Fritsche L, Heni M et al (2016) A novel insulin sensitivity index particularly suitable to measure insulin sensitivity during gestation. Acta Diabetol 53:1037\u20131044. https:\/\/doi.org\/10.1007\/s00592-016-0930-5","journal-title":"Acta Diabetol"},{"key":"6853_CR52","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487\u20131495. https:\/\/doi.org\/10.2337\/diacare.27.6.1487","journal-title":"Diabetes Care"},{"key":"6853_CR53","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/dme.12159","volume":"30","author":"AG Jones","year":"2013","unstructured":"Jones AG, Hattersley AT (2013) The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med 30:803\u2013817. https:\/\/doi.org\/10.1111\/dme.12159","journal-title":"Diabet Med"},{"key":"6853_CR54","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1055\/a-1998-6889","volume":"131","author":"S H\u00f6rber","year":"2023","unstructured":"H\u00f6rber S, Orth M, Fritsche A, Peter A (2023) Comparability of C-peptide measurements: current status and clinical relevance. Exp Clin Endocrinol Diabetes 131:173\u2013178. https:\/\/doi.org\/10.1055\/a-1998-6889","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"6853_CR55","doi-asserted-by":"publisher","unstructured":"Schleicher E, Kabytaev K, Nauck M et al (2025) Call for standardization of C-peptide measurement. J Diabetes Sci Technol 19322968251362848. https:\/\/doi.org\/10.1177\/19322968251362848","DOI":"10.1177\/19322968251362848"},{"key":"6853_CR56","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen MC, Shulman GI (2018) Mechanisms of insulin action and insulin resistance. Physiol Rev 98:2133\u20132223. https:\/\/doi.org\/10.1152\/physrev.00063.2017","journal-title":"Physiol Rev"},{"key":"6853_CR57","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.2337\/db13-1249","volume":"63","author":"BH Goodpaster","year":"2014","unstructured":"Goodpaster BH, Bertoldo A, Ng JM et al (2014) Interactions among glucose delivery, transport, and phosphorylation that underlie skeletal muscle insulin resistance in obesity and type 2 diabetes: studies with dynamic PET imaging. Diabetes 63:1058\u20131068. https:\/\/doi.org\/10.2337\/db13-1249","journal-title":"Diabetes"},{"key":"6853_CR58","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.2337\/db06-0762","volume":"55","author":"A Bertoldo","year":"2006","unstructured":"Bertoldo A, Pencek RR, Azuma K et al (2006) Interactions between delivery, transport, and phosphorylation of glucose in governing uptake into human skeletal muscle. Diabetes 55:3028\u20133037. https:\/\/doi.org\/10.2337\/db06-0762","journal-title":"Diabetes"},{"key":"6853_CR59","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1172\/JCI118460","volume":"97","author":"M Roden","year":"1996","unstructured":"Roden M, Perseghin G, Petersen KF et al (1996) The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans. J Clin Invest 97:642\u2013648. https:\/\/doi.org\/10.1172\/JCI118460","journal-title":"J Clin Invest"},{"key":"6853_CR60","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1530\/EJE-17-0882","volume":"178","author":"MJ Honka","year":"2018","unstructured":"Honka MJ, Latva-Rasku A, Bucci M et al (2018) Insulin-stimulated glucose uptake in skeletal muscle, adipose tissue and liver: a positron emission tomography study. Eur J Endocrinol 178:523\u2013531. https:\/\/doi.org\/10.1530\/EJE-17-0882","journal-title":"Eur J Endocrinol"},{"key":"6853_CR61","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1365-2362.1992.tb01458.x","volume":"22","author":"JK Powrie","year":"1992","unstructured":"Powrie JK, Smith GD, Hennessy TR et al (1992) Incomplete suppression of hepatic glucose production in non-insulin dependent diabetes mellitus measured with [6,6\u20132H2]glucose enriched glucose infusion during hyperinsulinaemic euglycaemic clamps. Eur J Clin Invest 22:244\u2013253. https:\/\/doi.org\/10.1111\/j.1365-2362.1992.tb01458.x","journal-title":"Eur J Clin Invest"},{"key":"6853_CR62","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.2337\/dc11-2339","volume":"35","author":"CS Tam","year":"2012","unstructured":"Tam CS, Xie W, Johnson WD, Cefalu WT, Redman LM, Ravussin E (2012) Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care 35:1605\u20131610. https:\/\/doi.org\/10.2337\/dc11-2339","journal-title":"Diabetes Care"},{"key":"6853_CR63","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1172\/JCI113489","volume":"81","author":"D Kelley","year":"1988","unstructured":"Kelley D, Mitrakou A, Marsh H et al (1988) Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load. J Clin Invest 81:1563\u20131571. https:\/\/doi.org\/10.1172\/JCI113489","journal-title":"J Clin Invest"},{"key":"6853_CR64","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1172\/JCI111938","volume":"76","author":"RA DeFronzo","year":"1985","unstructured":"DeFronzo RA, Gunnarsson R, Bj\u00f6rkman O, Olsson M, Wahren J (1985) Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest 76:149\u2013155. https:\/\/doi.org\/10.1172\/JCI111938","journal-title":"J Clin Invest"},{"key":"6853_CR65","doi-asserted-by":"publisher","first-page":"e154","DOI":"10.1371\/journal.pmed.0040154","volume":"4","author":"J Szendroedi","year":"2007","unstructured":"Szendroedi J, Schmid AL, Chmelik M et al (2007) Muscle mitochondrial ATP synthesis and glucose transport\/phosphorylation in type 2 diabetes. PLoS Med 4:e154. https:\/\/doi.org\/10.1371\/journal.pmed.0040154","journal-title":"PLoS Med"},{"key":"6853_CR66","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.2337\/diabetes.50.11.2579","volume":"50","author":"OP Bachmann","year":"2001","unstructured":"Bachmann OP, Dahl DB, Brechtel K et al (2001) Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 50:2579\u20132584. https:\/\/doi.org\/10.2337\/diabetes.50.11.2579","journal-title":"Diabetes"},{"key":"6853_CR67","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s001250051123","volume":"42","author":"M Krssak","year":"1999","unstructured":"Krssak M, Petersen KF, Dresner A et al (1999) Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42:113\u2013116. https:\/\/doi.org\/10.1007\/s001250051123","journal-title":"Diabetologia"},{"key":"6853_CR68","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.2337\/diabetes.48.5.1113","volume":"48","author":"S Jacob","year":"1999","unstructured":"Jacob S, Machann J, Rett K et al (1999) Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48:1113\u20131119. https:\/\/doi.org\/10.2337\/diabetes.48.5.1113","journal-title":"Diabetes"},{"key":"6853_CR69","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.2337\/diabetes.48.8.1600","volume":"48","author":"G Perseghin","year":"1999","unstructured":"Perseghin G, Scifo P, De Cobelli F et al (1999) Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H\u201313C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48:1600\u20131606. https:\/\/doi.org\/10.2337\/diabetes.48.8.1600","journal-title":"Diabetes"},{"key":"6853_CR70","doi-asserted-by":"publisher","first-page":"9597","DOI":"10.1073\/pnas.1409229111","volume":"111","author":"J Szendroedi","year":"2014","unstructured":"Szendroedi J, Yoshimura T, Phielix E et al (2014) Role of diacylglycerol activation of PKC\u03b8 in lipid-induced muscle insulin resistance in humans. Proc Natl Acad Sci U S A 111:9597\u20139602. https:\/\/doi.org\/10.1073\/pnas.1409229111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6853_CR71","doi-asserted-by":"publisher","first-page":"e96805","DOI":"10.1172\/jci.insight.96805","volume":"3","author":"L Perreault","year":"2018","unstructured":"Perreault L, Newsom SA, Strauss A et al (2018) Intracellular localization of diacylglycerols and sphingolipids influences insulin sensitivity and mitochondrial function in human skeletal muscle. JCI Insight 3:e96805. https:\/\/doi.org\/10.1172\/jci.insight.96805","journal-title":"JCI Insight"},{"key":"6853_CR72","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.2337\/db10-1221","volume":"60","author":"F Amati","year":"2011","unstructured":"Amati F, Dub\u00e9 JJ, Alvarez-Carnero E et al (2011) Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes? Diabetes 60:2588\u20132597. https:\/\/doi.org\/10.2337\/db10-1221","journal-title":"Diabetes"},{"key":"6853_CR73","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1462-8902.2004.00339.x","volume":"6","author":"J Machann","year":"2004","unstructured":"Machann J, H\u00e4ring H, Schick F, Stumvoll M (2004) Intramyocellular lipids and insulin resistance. Diabetes Obes Metab 6:239\u2013248. https:\/\/doi.org\/10.1111\/j.1462-8902.2004.00339.x","journal-title":"Diabetes Obes Metab"},{"key":"6853_CR74","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.2337\/db23-0353","volume":"72","author":"M Sch\u00f6n","year":"2023","unstructured":"Sch\u00f6n M, Zaharia OP, Strassburger K et al (2023) Intramyocellular triglyceride content during the early course of type 1 and type 2 diabetes. Diabetes 72:1483\u20131492. https:\/\/doi.org\/10.2337\/db23-0353","journal-title":"Diabetes"},{"key":"6853_CR75","doi-asserted-by":"publisher","first-page":"5755","DOI":"10.1210\/jcem.86.12.8075","volume":"86","author":"BH Goodpaster","year":"2001","unstructured":"Goodpaster BH, He J, Watkins S, Kelley DE (2001) Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 86:5755\u20135761. https:\/\/doi.org\/10.1210\/jcem.86.12.8075","journal-title":"J Clin Endocrinol Metab"},{"key":"6853_CR76","doi-asserted-by":"publisher","first-page":"e127928","DOI":"10.1172\/jci.insight.127928","volume":"4","author":"E Phielix","year":"2019","unstructured":"Phielix E, Begovatz P, Gancheva S et al (2019) Athletes feature greater rates of muscle glucose transport and glycogen synthesis during lipid infusion. JCI Insight 4:e127928. https:\/\/doi.org\/10.1172\/jci.insight.127928","journal-title":"JCI Insight"},{"key":"6853_CR77","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/hep.29465","volume":"67","author":"M Gaggini","year":"2018","unstructured":"Gaggini M, Carli F, Rosso C et al (2018) Altered amino acid concentrations in NAFLD: impact of obesity and insulin resistance. Hepatology 67:145\u2013158. https:\/\/doi.org\/10.1002\/hep.29465","journal-title":"Hepatology"},{"key":"6853_CR78","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrendo.2014.171","volume":"10","author":"CJ Lynch","year":"2014","unstructured":"Lynch CJ, Adams SH (2014) Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev Endocrinol 10:723\u2013736. https:\/\/doi.org\/10.1038\/nrendo.2014.171","journal-title":"Nat Rev Endocrinol"},{"key":"6853_CR79","doi-asserted-by":"publisher","first-page":"810","DOI":"10.2337\/diabetes.50.4.810","volume":"50","author":"G Boden","year":"2001","unstructured":"Boden G, Chen X, Capulong E, Mozzoli M (2001) Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. Diabetes 50:810\u2013816. https:\/\/doi.org\/10.2337\/diabetes.50.4.810","journal-title":"Diabetes"},{"key":"6853_CR80","doi-asserted-by":"publisher","first-page":"101820","DOI":"10.1016\/j.xcrm.2024.101820","volume":"5","author":"S Sabatini","year":"2024","unstructured":"Sabatini S, Sen P, Carli F et al (2024) Hepatic glucose production rises with the histological severity of metabolic dysfunction-associated steatohepatitis. Cell Rep Med 5:101820. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101820","journal-title":"Cell Rep Med"},{"key":"6853_CR81","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1172\/JCI77812","volume":"126","author":"VT Samuel","year":"2016","unstructured":"Samuel VT, Shulman GI (2016) The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest 126:12\u201322. https:\/\/doi.org\/10.1172\/JCI77812","journal-title":"J Clin Invest"},{"key":"6853_CR82","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.tem.2017.03.003","volume":"28","author":"PM Titchenell","year":"2017","unstructured":"Titchenell PM, Lazar MA, Birnbaum MJ (2017) Unraveling the regulation of hepatic metabolism by insulin. Trends Endocrinol Metab 28:497\u2013505. https:\/\/doi.org\/10.1016\/j.tem.2017.03.003","journal-title":"Trends Endocrinol Metab"},{"key":"6853_CR83","doi-asserted-by":"publisher","first-page":"E653","DOI":"10.1152\/ajpendo.00620.2020","volume":"320","author":"AC Carpentier","year":"2021","unstructured":"Carpentier AC (2021) 100th anniversary of the discovery of insulin perspective: insulin and adipose tissue fatty acid metabolism. Am J Physiol Endocrinol Metab 320:E653\u2013E670. https:\/\/doi.org\/10.1152\/ajpendo.00620.2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"6853_CR84","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1172\/JCI119867","volume":"100","author":"SD Mittelman","year":"1997","unstructured":"Mittelman SD, Fu YY, Rebrin K, Steil G, Bergman RN (1997) Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia. J Clin Invest 100:3121\u20133130. https:\/\/doi.org\/10.1172\/JCI119867","journal-title":"J Clin Invest"},{"key":"6853_CR85","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/S2213-8587(24)00127-X","volume":"12","author":"M Abdul-Ghani","year":"2024","unstructured":"Abdul-Ghani M, Maffei P, DeFronzo RA (2024) Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetes. Lancet Diabetes Endocrinol 12:674\u2013680. https:\/\/doi.org\/10.1016\/S2213-8587(24)00127-X","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6853_CR86","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jcmgh.2018.10.016","volume":"7","author":"D Santoleri","year":"2019","unstructured":"Santoleri D, Titchenell PM (2019) Resolving the paradox of hepatic insulin resistance. Cell Mol Gastroenterol Hepatol 7:447\u2013456. https:\/\/doi.org\/10.1016\/j.jcmgh.2018.10.016","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"6853_CR87","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115:1343\u20131351. https:\/\/doi.org\/10.1172\/JCI23621","journal-title":"J Clin Invest"},{"key":"6853_CR88","doi-asserted-by":"publisher","first-page":"114746","DOI":"10.1016\/j.celrep.2024.114746","volume":"43","author":"W Xu","year":"2024","unstructured":"Xu W, Zhang D, Ma Y et al (2024) Ceramide synthesis inhibitors prevent lipid-induced insulin resistance through the DAG-PKC\u03b5-insulin receptorT1150 phosphorylation pathway. Cell Rep 43:114746. https:\/\/doi.org\/10.1016\/j.celrep.2024.114746","journal-title":"Cell Rep"},{"key":"6853_CR89","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1194\/jlr.RA119000586","volume":"61","author":"A Abulizi","year":"2020","unstructured":"Abulizi A, Vatner DF, Ye Z et al (2020) Membrane-bound sn-1,2-diacylglycerols explain the dissociation of hepatic insulin resistance from hepatic steatosis in MTTP knockout mice. J Lipid Res 61:1565\u20131576. https:\/\/doi.org\/10.1194\/jlr.RA119000586","journal-title":"J Lipid Res"},{"key":"6853_CR90","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","volume":"78","author":"B Fromenty","year":"2023","unstructured":"Fromenty B, Roden M (2023) Mitochondrial alterations in fatty liver diseases. J Hepatol 78:415\u2013429. https:\/\/doi.org\/10.1016\/j.jhep.2022.09.020","journal-title":"J Hepatol"},{"key":"6853_CR91","doi-asserted-by":"publisher","first-page":"901","DOI":"10.2174\/0929867043455620","volume":"11","author":"M Krebs","year":"2004","unstructured":"Krebs M, Roden M (2004) Nutrient-induced insulin resistance in human skeletal muscle. Curr Med Chem 11:901\u2013908. https:\/\/doi.org\/10.2174\/0929867043455620","journal-title":"Curr Med Chem"},{"key":"6853_CR92","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00125-003-1129-1","volume":"46","author":"M Krebs","year":"2003","unstructured":"Krebs M, Brehm A, Krssak M et al (2003) Direct and indirect effects of amino acids on hepatic glucose metabolism in humans. Diabetologia 46:917\u2013925. https:\/\/doi.org\/10.1007\/s00125-003-1129-1","journal-title":"Diabetologia"},{"key":"6853_CR93","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2337\/diabetes.49.5.701","volume":"49","author":"M Roden","year":"2000","unstructured":"Roden M, Stingl H, Chandramouli V et al (2000) Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes 49:701\u2013707. https:\/\/doi.org\/10.2337\/diabetes.49.5.701","journal-title":"Diabetes"},{"key":"6853_CR94","doi-asserted-by":"publisher","unstructured":"Vangipurapu J, Stan\u010d\u00e1kov\u00e1 A, Kuulasmaa T et al; EGIR-RISC Study Group (2011) A novel surrogate index for hepatic insulin resistance. Diabetologia 54:540\u2013543 https:\/\/doi.org\/10.1007\/s00125-010-1966-7","DOI":"10.1007\/s00125-010-1966-7"},{"key":"6853_CR95","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2337\/dc06-1519","volume":"30","author":"MA Abdul-Ghani","year":"2007","unstructured":"Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30:89\u201394. https:\/\/doi.org\/10.2337\/dc06-1519","journal-title":"Diabetes Care"},{"key":"6853_CR96","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1210\/js.2018-00206","volume":"3","author":"R Muniyappa","year":"2019","unstructured":"Muniyappa R, Tella SH, Sortur S et al (2019) Predictive accuracy of surrogate indices for hepatic and skeletal muscle insulin sensitivity. J Endocr Soc 3:108\u2013118. https:\/\/doi.org\/10.1210\/js.2018-00206","journal-title":"J Endocr Soc"},{"key":"6853_CR97","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1053\/j.gastro.2007.04.068","volume":"133","author":"A Gastaldelli","year":"2007","unstructured":"Gastaldelli A, Cusi K, Pettiti M et al (2007) Relationship between hepatic\/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology 133:496\u2013506. https:\/\/doi.org\/10.1053\/j.gastro.2007.04.068","journal-title":"Gastroenterology"},{"key":"6853_CR98","doi-asserted-by":"publisher","first-page":"154892","DOI":"10.1016\/j.metabol.2021.154892","volume":"125","author":"L Mastrototaro","year":"2021","unstructured":"Mastrototaro L, Roden M (2021) Insulin resistance and insulin sensitizing agents. Metabolism 125:154892. https:\/\/doi.org\/10.1016\/j.metabol.2021.154892","journal-title":"Metabolism"},{"key":"6853_CR99","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","volume":"21","author":"C Koliaki","year":"2015","unstructured":"Koliaki C, Szendroedi J, Kaul K et al (2015) Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab 21:739\u2013746. https:\/\/doi.org\/10.1016\/j.cmet.2015.04.004","journal-title":"Cell Metab"},{"key":"6853_CR100","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jhep.2024.08.012","volume":"82","author":"S Kahl","year":"2025","unstructured":"Kahl S, Stra\u00dfburger K, Pacini G et al (2025) Dysglycemia and liver lipid content determine the relationship of insulin resistance with hepatic OXPHOS capacity in obesity. J Hepatol 82:417\u2013426. https:\/\/doi.org\/10.1016\/j.jhep.2024.08.012","journal-title":"J Hepatol"},{"key":"6853_CR101","doi-asserted-by":"publisher","first-page":"11337","DOI":"10.1074\/jbc.M114.623686","volume":"290","author":"S-X Tan","year":"2015","unstructured":"Tan S-X, Fisher-Wellman KH, Fazakerley DJ et al (2015) Selective insulin resistance in adipocytes. J Biol Chem 290:11337\u201311348. https:\/\/doi.org\/10.1074\/jbc.M114.623686","journal-title":"J Biol Chem"},{"key":"6853_CR102","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/joim.12071","volume":"274","author":"J Bor\u00e9n","year":"2013","unstructured":"Bor\u00e9n J, Taskinen MR, Olofsson SO, Levin M (2013) Ectopic lipid storage and insulin resistance: a harmful relationship. J Intern Med 274:25\u201340. https:\/\/doi.org\/10.1111\/joim.12071","journal-title":"J Intern Med"},{"key":"6853_CR103","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1210\/jc.2017-00047","volume":"102","author":"E S\u00f8ndergaard","year":"2017","unstructured":"S\u00f8ndergaard E, Espinosa De Ycaza AE, Morgan-Bathke M, Jensen MD (2017) How to measure adipose tissue insulin sensitivity. J Clin Endocrinol Metab 102:1193\u20131199. https:\/\/doi.org\/10.1210\/jc.2017-00047","journal-title":"J Clin Endocrinol Metab"},{"key":"6853_CR104","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/ijo.2017.110","volume":"41","author":"KW Ter Horst","year":"2017","unstructured":"Ter Horst KW, van Galen KA, Gilijamse PW et al (2017) Methods for quantifying adipose tissue insulin resistance in overweight\/obese humans. Int J Obes 41:1288\u20131294. https:\/\/doi.org\/10.1038\/ijo.2017.110","journal-title":"Int J Obes"},{"key":"6853_CR105","doi-asserted-by":"publisher","first-page":"E382","DOI":"10.1152\/ajpendo.1990.258.2.E382","volume":"258","author":"RR Wolfe","year":"1990","unstructured":"Wolfe RR, Klein S, Carraro F, Weber JM (1990) Role of triglyceride-fatty acid cycle in controlling fat metabolism in humans during and after exercise. Am J Physiol 258:E382\u2013E389. https:\/\/doi.org\/10.1152\/ajpendo.1990.258.2.E382","journal-title":"Am J Physiol"},{"key":"6853_CR106","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.metabol.2013.09.008","volume":"63","author":"NC Bush","year":"2014","unstructured":"Bush NC, Triay JM, Gathaiya NW, Hames KC, Jensen MD (2014) Contribution of very low-density lipoprotein triglyceride fatty acids to postabsorptive free fatty acid flux in obese humans. Metabolism 63:137\u2013140. https:\/\/doi.org\/10.1016\/j.metabol.2013.09.008","journal-title":"Metabolism"},{"key":"6853_CR107","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.2337\/db07-0654","volume":"56","author":"L Hodson","year":"2007","unstructured":"Hodson L, Bickerton AST, McQuaid SE et al (2007) The contribution of splanchnic fat to VLDL triglyceride is greater in insulin-resistant than insulin-sensitive men and women: studies in the postprandial state. Diabetes 56:2433\u20132441. https:\/\/doi.org\/10.2337\/db07-0654","journal-title":"Diabetes"},{"key":"6853_CR108","doi-asserted-by":"publisher","unstructured":"Gastaldelli A, Coggan AR, Wolfe RR (1985) Assessment of methods for improving tracer estimation of non-steady-state rate of appearance. J Appl Physiol\u00a087:1813\u20131822. https:\/\/doi.org\/10.1152\/jappl.1999.87.5.1813","DOI":"10.1152\/jappl.1999.87.5.1813"},{"key":"6853_CR109","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.jhep.2019.06.031","volume":"71","author":"C Rosso","year":"2019","unstructured":"Rosso C, Kazankov K, Younes R et al (2019) Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease. J Hepatol 71:1012\u20131021. https:\/\/doi.org\/10.1016\/j.jhep.2019.06.031","journal-title":"J Hepatol"},{"key":"6853_CR110","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2337\/diabetes.52.2.239","volume":"52","author":"O Tschritter","year":"2003","unstructured":"Tschritter O, Fritsche A, Thamer C et al (2003) Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52:239\u2013243. https:\/\/doi.org\/10.2337\/diabetes.52.2.239","journal-title":"Diabetes"},{"key":"6853_CR111","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1161\/CIRCULATIONAHA.112.001133","volume":"127","author":"M Margaritis","year":"2013","unstructured":"Margaritis M, Antonopoulos AS, Digby J et al (2013) Interactions between vascular wall and perivascular adipose tissue reveal novel roles for adiponectin in the regulation of endothelial nitric oxide synthase function in human vessels. Circulation 127:2209\u20132221. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.001133","journal-title":"Circulation"},{"key":"6853_CR112","doi-asserted-by":"publisher","first-page":"7449","DOI":"10.1073\/pnas.78.12.7449","volume":"78","author":"HG Mautner","year":"1981","unstructured":"Mautner HG, Pakula AA, Merrill RE (1981) Evidence for presence of an arginine residue in the coenzyme A binding site of choline acetyltransferase. Proc Natl Acad Sci U S A 78:7449\u20137452. https:\/\/doi.org\/10.1073\/pnas.78.12.7449","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6853_CR113","doi-asserted-by":"publisher","first-page":"101185","DOI":"10.1016\/j.jhepr.2024.101185","volume":"6","author":"F Carli","year":"2024","unstructured":"Carli F, Pepa GD, Sabatini S, Puig AV, Gastaldelli A (2024) Lipid metabolism in MASLD and MASH: from mechanism to the clinic. JHEP Rep 6:101185. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101185","journal-title":"JHEP Rep"},{"key":"6853_CR114","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41574-025-01221-w","volume":"22","author":"S Wangler","year":"2026","unstructured":"Wangler S, Jarczok MN, Ennis M et al (2026) The autonomic nervous system in the regulation of glucose and lipid metabolism. Nat Rev Endocrinol 22:274\u2013286. https:\/\/doi.org\/10.1038\/s41574-025-01221-w","journal-title":"Nat Rev Endocrinol"},{"key":"6853_CR115","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S2213-8587(20)30113-3","volume":"8","author":"S Kullmann","year":"2020","unstructured":"Kullmann S, Kleinridders A, Small DM et al (2020) Central nervous pathways of insulin action in the control of metabolism and food intake. Lancet Diabetes Endocrinol 8:524\u2013534. https:\/\/doi.org\/10.1016\/S2213-8587(20)30113-3","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6853_CR116","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3389\/fnins.2019.00521","volume":"13","author":"EM Rhea","year":"2019","unstructured":"Rhea EM, Banks WA (2019) Role of the blood-brain barrier in central nervous system insulin resistance. Front Neurosci 13:521. https:\/\/doi.org\/10.3389\/fnins.2019.00521","journal-title":"Front Neurosci"},{"key":"6853_CR117","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.14336\/AD.2023.0814","volume":"15","author":"EM Rhea","year":"2024","unstructured":"Rhea EM, Leclerc M, Yassine HN et al (2024) State of the science on brain insulin resistance and cognitive decline due to Alzheimer\u2019s disease. Aging Dis 15:1688\u20131725. https:\/\/doi.org\/10.14336\/AD.2023.0814","journal-title":"Aging Dis"},{"key":"6853_CR118","doi-asserted-by":"publisher","first-page":"e12934","DOI":"10.1111\/jne.12934","volume":"33","author":"M Hallschmid","year":"2021","unstructured":"Hallschmid M (2021) Intranasal insulin. J Neuroendocrinol 33:e12934. https:\/\/doi.org\/10.1111\/jne.12934","journal-title":"J Neuroendocrinol"},{"key":"6853_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000526717","volume":"113","author":"KMR Nijssen","year":"2023","unstructured":"Nijssen KMR, Mensink RP, Joris PJ (2023) Effects of intranasal insulin administration on cerebral blood flow and cognitive performance in adults: a systematic review of randomized, placebo-controlled intervention studies. Neuroendocrinology 113:1\u201313. https:\/\/doi.org\/10.1159\/000526717","journal-title":"Neuroendocrinology"},{"key":"6853_CR120","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3390\/jcm10071532","volume":"10","author":"E Rebelos","year":"2021","unstructured":"Rebelos E, Rinne JO, Nuutila P, Ekblad LL (2021) Brain glucose metabolism in health, obesity, and cognitive decline: does insulin have anything to do with it? A narrative review. J Clin Med 10:1532. https:\/\/doi.org\/10.3390\/jcm10071532","journal-title":"J Clin Med"},{"key":"6853_CR121","doi-asserted-by":"publisher","first-page":"e525","DOI":"10.1210\/clinem\/dgae570","volume":"110","author":"NJ Jensen","year":"2025","unstructured":"Jensen NJ, Porse AJ, Wodschow HZ et al (2025) Relation of insulin resistance to brain glucose metabolism in fasting and hyperinsulinemic states: a systematic review and meta-analysis. J Clin Endocrinol Metab 110:e525\u2013e537. https:\/\/doi.org\/10.1210\/clinem\/dgae570","journal-title":"J Clin Endocrinol Metab"},{"key":"6853_CR122","doi-asserted-by":"publisher","first-page":"100125","DOI":"10.1016\/j.bionps.2025.100125","volume":"12","author":"G Reid","year":"2025","unstructured":"Reid G, Sargent B, Bauermeister S, Adler A, Koychev I (2025) A systematic review of in vivo brain insulin resistance biomarkers in humans. Biomark Neuropsychiatry 12:100125. https:\/\/doi.org\/10.1016\/j.bionps.2025.100125","journal-title":"Biomark Neuropsychiatry"},{"key":"6853_CR123","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1172\/JCI118124","volume":"96","author":"AD Baron","year":"1995","unstructured":"Baron AD, Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G (1995) Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest 96:786\u2013792. https:\/\/doi.org\/10.1172\/JCI118124","journal-title":"J Clin Invest"},{"key":"6853_CR124","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.2337\/diabetes.53.6.1418","volume":"53","author":"MA Vincent","year":"2004","unstructured":"Vincent MA, Clerk LH, Lindner JR et al (2004) Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo. Diabetes 53:1418\u20131423. https:\/\/doi.org\/10.2337\/diabetes.53.6.1418","journal-title":"Diabetes"},{"key":"6853_CR125","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S1056-8727(01)00209-4","volume":"16","author":"AD Baron","year":"2002","unstructured":"Baron AD (2002) Insulin resistance and vascular function. J Diabetes Complications 16:92\u2013102. https:\/\/doi.org\/10.1016\/S1056-8727(01)00209-4","journal-title":"J Diabetes Complications"},{"key":"6853_CR126","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1046\/j.1365-2362.2003.01106.x","volume":"33","author":"H Herkner","year":"2003","unstructured":"Herkner H, Klein N, Joukhadar C et al (2003) Transcapillary insulin transfer in human skeletal muscle. Eur J Clin Invest 33:141\u2013146. https:\/\/doi.org\/10.1046\/j.1365-2362.2003.01106.x","journal-title":"Eur J Clin Invest"},{"key":"6853_CR127","doi-asserted-by":"publisher","first-page":"828","DOI":"10.2337\/db07-1444","volume":"57","author":"JD Chiu","year":"2008","unstructured":"Chiu JD, Richey JM, Harrison LN et al (2008) Direct administration of insulin into skeletal muscle reveals that the transport of insulin across the capillary endothelium limits the time course of insulin to activate glucose disposal. Diabetes 57:828\u2013835. https:\/\/doi.org\/10.2337\/db07-1444","journal-title":"Diabetes"},{"key":"6853_CR128","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s00125-009-1313-z","volume":"52","author":"EJ Barrett","year":"2009","unstructured":"Barrett EJ, Eggleston EM, Inyard AC et al (2009) The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action. Diabetologia 52:752\u2013764. https:\/\/doi.org\/10.1007\/s00125-009-1313-z","journal-title":"Diabetologia"},{"key":"6853_CR129","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1210\/me.2012-1003","volume":"26","author":"H Wang","year":"2012","unstructured":"Wang H, Wang AX, Barrett EJ (2012) Insulin-induced endothelial cell cortical actin filament remodeling: a requirement for trans-endothelial insulin transport. Mol Endocrinol 26:1327\u20131338. https:\/\/doi.org\/10.1210\/me.2012-1003","journal-title":"Mol Endocrinol"},{"key":"6853_CR130","doi-asserted-by":"publisher","first-page":"E629","DOI":"10.1152\/ajpendo.00247.2020","volume":"319","author":"R Muniyappa","year":"2020","unstructured":"Muniyappa R, Chen H, Montagnani M, Sherman A, Quon MJ (2020) Endothelial dysfunction due to selective insulin resistance in vascular endothelium: insights from mechanistic modeling. Am J Physiol Endocrinol Metab 319:E629\u2013E646. https:\/\/doi.org\/10.1152\/ajpendo.00247.2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"6853_CR131","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrneph.2016.145","volume":"12","author":"F Artunc","year":"2016","unstructured":"Artunc F, Schleicher E, Weigert C, Fritsche A, Stefan N, H\u00e4ring HU (2016) The impact of insulin resistance on the kidney and vasculature. Nat Rev Nephrol 12:721\u2013737. https:\/\/doi.org\/10.1038\/nrneph.2016.145","journal-title":"Nat Rev Nephrol"},{"key":"6853_CR132","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11154-012-9229-1","volume":"14","author":"R Muniyappa","year":"2013","unstructured":"Muniyappa R, Sowers JR (2013) Role of insulin resistance in endothelial dysfunction. Rev Endocr Metab Disord 14:5\u201312. https:\/\/doi.org\/10.1007\/s11154-012-9229-1","journal-title":"Rev Endocr Metab Disord"},{"key":"6853_CR133","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","volume":"115","author":"JE Deanfield","year":"2007","unstructured":"Deanfield JE, Halcox JP, Rabelink TJ (2007) Endothelial function and dysfunction: testing and clinical relevance. Circulation 115:1285\u20131295. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.652859","journal-title":"Circulation"},{"key":"6853_CR134","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fcvm.2018.00068","volume":"5","author":"QG Karwi","year":"2018","unstructured":"Karwi QG, Uddin GM, Ho KL, Lopaschuk GD (2018) Loss of metabolic flexibility in the failing heart. Front Cardiovasc Med 5:68. https:\/\/doi.org\/10.3389\/fcvm.2018.00068","journal-title":"Front Cardiovasc Med"},{"key":"6853_CR135","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.bbalip.2016.03.020","volume":"1861","author":"A Fukushima","year":"2016","unstructured":"Fukushima A, Lopaschuk GD (2016) Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes. Biochim Biophys Acta 1861:1525\u20131534. https:\/\/doi.org\/10.1016\/j.bbalip.2016.03.020","journal-title":"Biochim Biophys Acta"},{"key":"6853_CR136","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.2337\/diabetes.51.10.3020","volume":"51","author":"P Iozzo","year":"2002","unstructured":"Iozzo P, Chareonthaitawee P, Dutka D, Betteridge DJ, Ferrannini E, Camici PG (2002) Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. Diabetes 51:3020\u20133024. https:\/\/doi.org\/10.2337\/diabetes.51.10.3020","journal-title":"Diabetes"},{"key":"6853_CR137","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1900\/RDS.2011.8.403","volume":"8","author":"MA Guzzardi","year":"2011","unstructured":"Guzzardi MA, Iozzo P (2011) Fatty heart, cardiac damage, and inflammation. Rev Diabet Stud 8:403\u2013417. https:\/\/doi.org\/10.1900\/RDS.2011.8.403","journal-title":"Rev Diabet Stud"},{"key":"6853_CR138","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/jpm12010030","volume":"12","author":"JR Herance","year":"2022","unstructured":"Herance JR, Sim\u00f3 R, Velasquez MA et al (2022) Phenotyping type 2 diabetes in terms of myocardial insulin resistance and its potential cardiovascular consequences: a new strategy based on 18F-FDG PET\/CT. J Pers Med 12:30. https:\/\/doi.org\/10.3390\/jpm12010030","journal-title":"J Pers Med"},{"key":"6853_CR139","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1007\/s00259-002-0972-5","volume":"29","author":"KF Kofoed","year":"2002","unstructured":"Kofoed KF, Hove JD, Freiberg J, H\u00f8st U, Holm S, Kelbaek H (2002) Variability of insulin-stimulated myocardial glucose uptake in healthy elderly subjects. Eur J Nucl Med Mol Imaging 29:1600\u20131607. https:\/\/doi.org\/10.1007\/s00259-002-0972-5","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6853_CR140","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41581-026-01066-0","volume":"22","author":"H Zaitoon","year":"2026","unstructured":"Zaitoon H, Abdul-Ghani M, DeFronzo RA (2026) Insulin resistance and hyperinsulinaemia in kidney disease: mechanisms and metabolic effects. Nat Rev Nephrol 22:474\u2013486. https:\/\/doi.org\/10.1038\/s41581-026-01066-0","journal-title":"Nat Rev Nephrol"},{"key":"6853_CR141","doi-asserted-by":"publisher","first-page":"F974","DOI":"10.1152\/ajprenal.00149.2007","volume":"293","author":"S Tiwari","year":"2007","unstructured":"Tiwari S, Riazi S, Ecelbarger CA (2007) Insulin\u2019s impact on renal sodium transport and blood pressure in health, obesity, and diabetes. Am J Physiol Renal Physiol 293:F974\u2013F984. https:\/\/doi.org\/10.1152\/ajprenal.00149.2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"6853_CR142","doi-asserted-by":"publisher","first-page":"155382","DOI":"10.1016\/j.metabol.2022.155382","volume":"141","author":"E Rebelos","year":"2023","unstructured":"Rebelos E, Mari A, Oikonen V, Iida H, Nuutila P, Ferrannini E (2023) Evaluation of renal glucose uptake with [18F]FDG-PET: methodological advancements and metabolic outcomes. Metabolism 141:155382. https:\/\/doi.org\/10.1016\/j.metabol.2022.155382","journal-title":"Metabolism"},{"key":"6853_CR143","doi-asserted-by":"publisher","first-page":"155142","DOI":"10.1016\/j.metabol.2022.155142","volume":"129","author":"L Norton","year":"2022","unstructured":"Norton L, Shannon C, Gastaldelli A, DeFronzo RA (2022) Insulin: the master regulator of glucose metabolism. Metabolism 129:155142. https:\/\/doi.org\/10.1016\/j.metabol.2022.155142","journal-title":"Metabolism"},{"key":"6853_CR144","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.2337\/diabetes.50.10.2337","volume":"50","author":"A Virkam\u00e4ki","year":"2001","unstructured":"Virkam\u00e4ki A, Korsheninnikova E, Sepp\u00e4l\u00e4-Lindroos A et al (2001) Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. Diabetes 50:2337\u20132343. https:\/\/doi.org\/10.2337\/diabetes.50.10.2337","journal-title":"Diabetes"},{"key":"6853_CR145","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1111\/liv.15377","volume":"42","author":"C Saponaro","year":"2022","unstructured":"Saponaro C, Sabatini S, Gaggini M et al (2022) Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals. Liver Int 42:2418\u20132427. https:\/\/doi.org\/10.1111\/liv.15377","journal-title":"Liver Int"},{"key":"6853_CR146","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3390\/nu5051544","volume":"5","author":"M Gaggini","year":"2013","unstructured":"Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A (2013) Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 5:1544\u20131560. https:\/\/doi.org\/10.3390\/nu5051544","journal-title":"Nutrients"},{"key":"6853_CR147","doi-asserted-by":"publisher","first-page":"E291","DOI":"10.1152\/ajpendo.00143.2023","volume":"325","author":"KL Whytock","year":"2023","unstructured":"Whytock KL, Pino MF, Sun Y et al (2023) Comprehensive interrogation of human skeletal muscle reveals a dissociation between insulin resistance and mitochondrial capacity. Am J Physiol Endocrinol Metab 325:E291\u2013E302. https:\/\/doi.org\/10.1152\/ajpendo.00143.2023","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"6853_CR148","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/hep.28985","volume":"65","author":"F Bril","year":"2017","unstructured":"Bril F, Barb D, Portilla-Sanchez P et al (2017) Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease. Hepatology 65:1132\u20131144. https:\/\/doi.org\/10.1002\/hep.28985","journal-title":"Hepatology"},{"key":"6853_CR149","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1210\/jc.2003-031941","volume":"89","author":"A Gastaldelli","year":"2004","unstructured":"Gastaldelli A, Miyazaki Y, Pettiti M et al (2004) Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis. J Clin Endocrinol Metab 89:3914\u20133921. https:\/\/doi.org\/10.1210\/jc.2003-031941","journal-title":"J Clin Endocrinol Metab"},{"key":"6853_CR150","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1210\/jc.2010-1621","volume":"96","author":"S Bajpeyi","year":"2011","unstructured":"Bajpeyi S, Pasarica M, Moro C et al (2011) Skeletal muscle mitochondrial capacity and insulin resistance in type 2 diabetes. J Clin Endocrinol Metab 96:1160\u20131168. https:\/\/doi.org\/10.1210\/jc.2010-1621","journal-title":"J Clin Endocrinol Metab"},{"key":"6853_CR151","doi-asserted-by":"publisher","unstructured":"Szendroedi J, Saxena A, Weber KS et al; GDS Group (2016) Cohort profile: the German Diabetes Study (GDS). Cardiovasc Diabetol 15:59. https:\/\/doi.org\/10.1186\/s12933-016-0374-9","DOI":"10.1186\/s12933-016-0374-9"},{"key":"6853_CR152","doi-asserted-by":"publisher","first-page":"5320156","DOI":"10.1155\/2019\/5320156","volume":"2019","author":"U Kampmann","year":"2019","unstructured":"Kampmann U, Knorr S, Fuglsang J, Ovesen P (2019) Determinants of maternal insulin resistance during pregnancy: an updated overview. J Diabetes Res 2019:5320156. https:\/\/doi.org\/10.1155\/2019\/5320156","journal-title":"J Diabetes Res"},{"key":"6853_CR153","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.2337\/db11-1478","volume":"61","author":"A Saad","year":"2012","unstructured":"Saad A, Man CD, Nandy DK et al (2012) Diurnal pattern to insulin secretion and insulin action in healthy individuals. Diabetes 61:2691\u20132700. https:\/\/doi.org\/10.2337\/db11-1478","journal-title":"Diabetes"},{"key":"6853_CR154","doi-asserted-by":"publisher","first-page":"750","DOI":"10.2337\/diab.41.6.750","volume":"41","author":"A Lee","year":"1992","unstructured":"Lee A, Ader M, Bray GA, Bergman RN (1992) Diurnal variation in glucose tolerance: cyclic suppression of insulin action and insulin secretion in normal-weight, but not obese, subjects. Diabetes 41:750\u2013759. https:\/\/doi.org\/10.2337\/diab.41.6.750","journal-title":"Diabetes"},{"key":"6853_CR155","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.2337\/db22-0721","volume":"72","author":"P Lucidi","year":"2023","unstructured":"Lucidi P, Perriello G, Porcellati F et al (2023) Diurnal cycling of insulin sensitivity in type 2 diabetes: evidence for deviation from physiology at an early stage. Diabetes 72:1364\u20131373. https:\/\/doi.org\/10.2337\/db22-0721","journal-title":"Diabetes"},{"key":"6853_CR156","doi-asserted-by":"publisher","first-page":"7789","DOI":"10.1073\/pnas.1722295115","volume":"115","author":"J Wefers","year":"2018","unstructured":"Wefers J, van Moorsel D, Hansen J et al (2018) Circadian misalignment induces fatty acid metabolism gene profiles and compromises insulin sensitivity in human skeletal muscle. Proc Natl Acad Sci U S A 115:7789\u20137794. https:\/\/doi.org\/10.1073\/pnas.1722295115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6853_CR157","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.2337\/db10-0519","volume":"59","author":"J Hoeks","year":"2010","unstructured":"Hoeks J, van Herpen NA, Mensink M et al (2010) Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance. Diabetes 59:2117\u20132125. https:\/\/doi.org\/10.2337\/db10-0519","journal-title":"Diabetes"},{"key":"6853_CR158","first-page":"533","volume":"20","author":"K Lundbaek","year":"1948","unstructured":"Lundbaek K (1948) Metabolic abnormalities in starvation diabetes. Yale J Biol Med 20:533\u2013544","journal-title":"Yale J Biol Med"},{"key":"6853_CR159","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1172\/JCI111982","volume":"76","author":"O Bj\u00f6rkman","year":"1985","unstructured":"Bj\u00f6rkman O, Eriksson LS (1985) Influence of a 60-hour fast on insulin-mediated splanchnic and peripheral glucose metabolism in humans. J Clin Invest 76:87\u201392. https:\/\/doi.org\/10.1172\/JCI111982","journal-title":"J Clin Invest"},{"key":"6853_CR160","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1016\/j.numecd.2024.09.030","volume":"34","author":"P Sedivy","year":"2024","unstructured":"Sedivy P, Dusilova T, Setinova B et al (2024) Liver fat response to two days fasting and two days isocaloric high-carbohydrate refeeding in lean and obese women. Nutr Metab Cardiovasc Dis 34:2690\u20132695. https:\/\/doi.org\/10.1016\/j.numecd.2024.09.030","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"6853_CR161","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.nutr.26.061505.111258","volume":"26","author":"GF Cahill Jr","year":"2006","unstructured":"Cahill GF Jr (2006) Fuel metabolism in starvation. Annu Rev Nutr 26:1\u201322. https:\/\/doi.org\/10.1146\/annurev.nutr.26.061505.111258","journal-title":"Annu Rev Nutr"},{"key":"6853_CR162","doi-asserted-by":"publisher","first-page":"e134520","DOI":"10.1172\/jci.insight.134520","volume":"5","author":"T Sarabhai","year":"2020","unstructured":"Sarabhai T, Kahl S, Szendroedi J et al (2020) Monounsaturated fat rapidly induces hepatic gluconeogenesis and whole-body insulin resistance. JCI Insight 5:e134520. https:\/\/doi.org\/10.1172\/jci.insight.134520","journal-title":"JCI Insight"},{"key":"6853_CR163","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1172\/JCI118742","volume":"97","author":"M Roden","year":"1996","unstructured":"Roden M, Price TB, Perseghin G et al (1996) Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97:2859\u20132865. https:\/\/doi.org\/10.1172\/JCI118742","journal-title":"J Clin Invest"},{"key":"6853_CR164","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2337\/diabetes.48.2.358","volume":"48","author":"M Roden","year":"1999","unstructured":"Roden M, Krssak M, Stingl H et al (1999) Rapid impairment of skeletal muscle glucose transport\/phosphorylation by free fatty acids in humans. Diabetes 48:358\u2013364. https:\/\/doi.org\/10.2337\/diabetes.48.2.358","journal-title":"Diabetes"},{"key":"6853_CR165","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1172\/JCI117252","volume":"93","author":"G Boden","year":"1994","unstructured":"Boden G, Chen X, Ruiz J, White JV, Rossetti L (1994) Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93:2438\u20132446. https:\/\/doi.org\/10.1172\/JCI117252","journal-title":"J Clin Invest"},{"key":"6853_CR166","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.2337\/diabetes.52.10.2461","volume":"52","author":"S Kashyap","year":"2003","unstructured":"Kashyap S, Belfort R, Gastaldelli A et al (2003) A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52:2461\u20132474. https:\/\/doi.org\/10.2337\/diabetes.52.10.2461","journal-title":"Diabetes"},{"key":"6853_CR167","doi-asserted-by":"publisher","first-page":"598","DOI":"10.2337\/db16-0530","volume":"66","author":"R Kj\u00f8bsted","year":"2017","unstructured":"Kj\u00f8bsted R, Munk-Hansen N, Birk JB et al (2017) Enhanced muscle insulin sensitivity after contraction\/exercise is mediated by AMPK. Diabetes 66:598\u2013612. https:\/\/doi.org\/10.2337\/db16-0530","journal-title":"Diabetes"},{"key":"6853_CR168","doi-asserted-by":"publisher","first-page":"857","DOI":"10.2337\/db22-0666","volume":"72","author":"R Kj\u00f8bsted","year":"2023","unstructured":"Kj\u00f8bsted R, Kristensen JM, Eskesen NO et al (2023) TBC1D4-S711 controls skeletal muscle insulin sensitization after exercise and contraction. Diabetes 72:857\u2013871. https:\/\/doi.org\/10.2337\/db22-0666","journal-title":"Diabetes"},{"key":"6853_CR169","doi-asserted-by":"publisher","first-page":"E726","DOI":"10.1152\/ajpendo.1984.247.6.E726","volume":"247","author":"T Ploug","year":"1984","unstructured":"Ploug T, Galbo H, Richter EA (1984) Increased muscle glucose uptake during contractions: no need for insulin. Am J Physiol 247:E726\u2013E731. https:\/\/doi.org\/10.1152\/ajpendo.1984.247.6.E726","journal-title":"Am J Physiol"},{"key":"6853_CR170","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.2337\/db19-0050","volume":"68","author":"R Kj\u00f8bsted","year":"2019","unstructured":"Kj\u00f8bsted R, Roll JLW, J\u00f8rgensen NO et al (2019) AMPK and TBC1D1 regulate muscle glucose uptake after, but not during, exercise and contraction. Diabetes 68:1427\u20131440. https:\/\/doi.org\/10.2337\/db19-0050","journal-title":"Diabetes"},{"key":"6853_CR171","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrendo.2016.162","volume":"13","author":"L Sylow","year":"2017","unstructured":"Sylow L, Kleinert M, Richter EA, Jensen TE (2017) Exercise-stimulated glucose uptake: regulation and implications for glycaemic control. Nat Rev Endocrinol 13:133\u2013148. https:\/\/doi.org\/10.1038\/nrendo.2016.162","journal-title":"Nat Rev Endocrinol"},{"key":"6853_CR172","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1007\/s00125-010-1764-2","volume":"53","author":"E Phielix","year":"2010","unstructured":"Phielix E, Meex R, Moonen-Kornips E, Hesselink MKC, Schrauwen P (2010) Exercise training increases mitochondrial content and ex vivo mitochondrial function similarly in patients with type 2 diabetes and in control individuals. Diabetologia 53:1714\u20131721. https:\/\/doi.org\/10.1007\/s00125-010-1764-2","journal-title":"Diabetologia"},{"key":"6853_CR173","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.2337\/dc18-0296","volume":"41","author":"NA Stephens","year":"2018","unstructured":"Stephens NA, Brouwers B, Eroshkin AM et al (2018) Exercise response variations in skeletal muscle PCr recovery rate and insulin sensitivity relate to muscle epigenomic profiles in individuals with type 2 diabetes. Diabetes Care 41:2245\u20132254. https:\/\/doi.org\/10.2337\/dc18-0296","journal-title":"Diabetes Care"},{"key":"6853_CR174","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00125-006-0475-1","volume":"50","author":"VB Schrauwen-Hinderling","year":"2007","unstructured":"Schrauwen-Hinderling VB, Kooi ME, Hesselink MKC et al (2007) Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 50:113\u2013120. https:\/\/doi.org\/10.1007\/s00125-006-0475-1","journal-title":"Diabetologia"},{"key":"6853_CR175","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1001\/jamainternmed.2013.7783","volume":"173","author":"TPJ Solomon","year":"2013","unstructured":"Solomon TPJ, Malin SK, Karstoft K, Haus JM, Kirwan JP (2013) The influence of hyperglycemia on the therapeutic effect of exercise on glycemic control in patients with type 2 diabetes mellitus. JAMA Intern Med 173:1834\u20131836. https:\/\/doi.org\/10.1001\/jamainternmed.2013.7783","journal-title":"JAMA Intern Med"},{"key":"6853_CR176","doi-asserted-by":"publisher","first-page":"155910","DOI":"10.1016\/j.metabol.2024.155910","volume":"155","author":"S Sabatini","year":"2024","unstructured":"Sabatini S, Nolan JJ, O\u2019Donoghue G et al (2024) Baseline phenotypes with preserved \u03b2-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies. Metabolism 155:155910. https:\/\/doi.org\/10.1016\/j.metabol.2024.155910","journal-title":"Metabolism"},{"key":"6853_CR177","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.2337\/diacare.28.9.2322","volume":"28","author":"HE Lebovitz","year":"2005","unstructured":"Lebovitz HE, Banerji MA (2005) Point: visceral adiposity is causally related to insulin resistance. Diabetes Care 28:2322\u20132325. https:\/\/doi.org\/10.2337\/diacare.28.9.2322","journal-title":"Diabetes Care"},{"key":"6853_CR178","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.2337\/diacare.28.9.2326","volume":"28","author":"JM Miles","year":"2005","unstructured":"Miles JM, Jensen MD (2005) Counterpoint: visceral adiposity is not causally related to insulin resistance. Diabetes Care 28:2326\u20132328. https:\/\/doi.org\/10.2337\/diacare.28.9.2326","journal-title":"Diabetes Care"},{"key":"6853_CR179","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.2337\/db22-0315","volume":"71","author":"H Yamazaki","year":"2022","unstructured":"Yamazaki H, Tauchi S, Machann J et al (2022) Fat distribution patterns and future type 2 diabetes. Diabetes 71:1937\u20131945. https:\/\/doi.org\/10.2337\/db22-0315","journal-title":"Diabetes"},{"key":"6853_CR180","doi-asserted-by":"publisher","unstructured":"Ennis M, Yamazaki H, Tauchi S et al (2025) Organ fat, not general obesity, defines risk for diabetes, inflammation, and comorbidities.\u00a0MedRxiv (Preprint). 29 Dec 2025. https:\/\/doi.org\/10.64898\/2025.12.22.25342850","DOI":"10.64898\/2025.12.22.25342850"},{"key":"6853_CR181","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s00125-020-05170-z","volume":"63","author":"A Gemmink","year":"2020","unstructured":"Gemmink A, Schrauwen P, Hesselink MKC (2020) Exercising your fat (metabolism) into shape: a muscle-centred view. Diabetologia 63:1453\u20131463. https:\/\/doi.org\/10.1007\/s00125-020-05170-z","journal-title":"Diabetologia"},{"key":"6853_CR182","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/joim.12729","volume":"284","author":"E Zacharewicz","year":"2018","unstructured":"Zacharewicz E, Hesselink MKC, Schrauwen P (2018) Exercise counteracts lipotoxicity by improving lipid turnover and lipid droplet quality. J Intern Med 284:505\u2013518. https:\/\/doi.org\/10.1111\/joim.12729","journal-title":"J Intern Med"},{"key":"6853_CR183","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s00424-005-1509-0","volume":"451","author":"LJC van Loon","year":"2006","unstructured":"van Loon LJC, Goodpaster BH (2006) Increased intramuscular lipid storage in the insulin-resistant and endurance-trained state. Pflugers Arch 451:606\u2013616. https:\/\/doi.org\/10.1007\/s00424-005-1509-0","journal-title":"Pflugers Arch"},{"key":"6853_CR184","doi-asserted-by":"publisher","first-page":"E882","DOI":"10.1152\/ajpendo.00769.2007","volume":"294","author":"JJ Dub\u00e9","year":"2008","unstructured":"Dub\u00e9 JJ, Amati F, Stefanovic-Racic M, Toledo FGS, Sauers SE, Goodpaster BH (2008) Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete\u2019s paradox revisited. Am J Physiol Endocrinol Metab 294:E882\u2013E888. https:\/\/doi.org\/10.1152\/ajpendo.00769.2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"6853_CR185","doi-asserted-by":"publisher","first-page":"134","DOI":"10.2337\/dbi24-0030","volume":"74","author":"JF Horowitz","year":"2025","unstructured":"Horowitz JF, Goodpaster BH (2025) Mechanistic insights into the exercise-induced changes in muscle lipids and insulin sensitivity: expanding on the \"athlete\u2019s paradox\u201d: revisiting a 2011 diabetes classic by Amati et al. Diabetes 74:134\u2013137. https:\/\/doi.org\/10.2337\/dbi24-0030","journal-title":"Diabetes"},{"key":"6853_CR186","doi-asserted-by":"publisher","first-page":"eadr8849","DOI":"10.1126\/sciadv.adr8849","volume":"11","author":"D Pesta","year":"2025","unstructured":"Pesta D, Anadol-Schmitz E, Sarabhai T et al (2025) Determinants of increased muscle insulin sensitivity of exercise-trained versus sedentary normal weight and overweight individuals. Sci Adv 11:eadr8849. https:\/\/doi.org\/10.1126\/sciadv.adr8849","journal-title":"Sci Adv"},{"key":"6853_CR187","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.cmet.2025.12.016","volume":"38","author":"N Trinks","year":"2026","unstructured":"Trinks N, Gancheva S, P\u00fctzer J et al (2026) Blood-flow restriction resistance training improves skeletal muscle mitochondrial capacity and cardiovascular risk factors in type 2 diabetes. Cell Metab 38:812-823.e6. https:\/\/doi.org\/10.1016\/j.cmet.2025.12.016","journal-title":"Cell Metab"},{"key":"6853_CR188","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2337\/dc23-1156","volume":"47","author":"FM Zuraikat","year":"2024","unstructured":"Zuraikat FM, Laferr\u00e8re B, Cheng B et al (2024) Chronic insufficient sleep in women impairs insulin sensitivity independent of adiposity changes: results of a randomized trial. Diabetes Care 47:117\u2013125. https:\/\/doi.org\/10.2337\/dc23-1156","journal-title":"Diabetes Care"},{"key":"6853_CR189","doi-asserted-by":"publisher","first-page":"zsad313","DOI":"10.1093\/sleep\/zsad313","volume":"47","author":"C Dutil","year":"2024","unstructured":"Dutil C, Podinic I, Featherstone RB et al (2024) Sleep and insulin sensitivity in adolescents at risk of type 2 diabetes: the Sleep Manipulation in Adolescents at Risk of Type 2 Diabetes randomized crossover study. Sleep 47:zsad313. https:\/\/doi.org\/10.1093\/sleep\/zsad313","journal-title":"Sleep"},{"key":"6853_CR190","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/nm.2214","volume":"16","author":"EE Zhang","year":"2010","unstructured":"Zhang EE, Liu Y, Dentin R et al (2010) Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis. Nat Med 16:1152\u20131156. https:\/\/doi.org\/10.1038\/nm.2214","journal-title":"Nat Med"},{"key":"6853_CR191","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.2337\/dc09-0267","volume":"32","author":"F Amati","year":"2009","unstructured":"Amati F, Dub\u00e9 JJ, Coen PM, Stefanovic-Racic M, Toledo FGS, Goodpaster BH (2009) Physical inactivity and obesity underlie the insulin resistance of aging. Diabetes Care 32:1547\u20131549. https:\/\/doi.org\/10.2337\/dc09-0267","journal-title":"Diabetes Care"},{"key":"6853_CR192","doi-asserted-by":"publisher","first-page":"4773","DOI":"10.1038\/s41467-021-24956-2","volume":"12","author":"L Grevendonk","year":"2021","unstructured":"Grevendonk L, Connell NJ, McCrum C et al (2021) Impact of aging and exercise on skeletal muscle mitochondrial capacity, energy metabolism, and physical function. Nat Commun 12:4773. https:\/\/doi.org\/10.1038\/s41467-021-24956-2","journal-title":"Nat Commun"},{"key":"6853_CR193","doi-asserted-by":"publisher","first-page":"CC01-3","DOI":"10.7860\/JCDR\/2014\/10068.5081","volume":"8","author":"AD Sonagra","year":"2014","unstructured":"Sonagra AD, Biradar SM, Dattatreya K, Jayaprakash Murthy DS (2014) Normal pregnancy: a state of insulin resistance. J Clin Diagn Res 8:CC01-3. https:\/\/doi.org\/10.7860\/JCDR\/2014\/10068.5081","journal-title":"J Clin Diagn Res"},{"key":"6853_CR194","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00125-025-06647-5","volume":"69","author":"NJD Verhoog","year":"2026","unstructured":"Verhoog NJD, Africander D, Storbeck K-H (2026) Sex steroids, SHBG and type 2 diabetes in women: what do we really know? Diabetologia 69:837\u2013854. https:\/\/doi.org\/10.1007\/s00125-025-06647-5","journal-title":"Diabetologia"},{"key":"6853_CR195","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3389\/fendo.2019.00090","volume":"10","author":"SZ Lutz","year":"2019","unstructured":"Lutz SZ, Wagner R, Fritsche L et al (2019) Sex-specific associations of testosterone with metabolic traits. Front Endocrinol (Lausanne) 10:90. https:\/\/doi.org\/10.3389\/fendo.2019.00090","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6853_CR196","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1210\/clinem\/dgaf282","volume":"111","author":"SJ Blackwood","year":"2025","unstructured":"Blackwood SJ, Tischer D, Pont\u00e9n M, Moberg M, Katz A (2025) Relationship between insulin sensitivity and hyperinsulinemia in early insulin resistance is sex-dependent. J Clin Endocrinol Metab 111:e234\u2013e239. https:\/\/doi.org\/10.1210\/clinem\/dgaf282","journal-title":"J Clin Endocrinol Metab"},{"key":"6853_CR197","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3389\/fendo.2014.00195","volume":"5","author":"A-M Lundsgaard","year":"2014","unstructured":"Lundsgaard A-M, Kiens B (2014) Gender differences in skeletal muscle substrate metabolism - molecular mechanisms and insulin sensitivity. Front Endocrinol (Lausanne) 5:195. https:\/\/doi.org\/10.3389\/fendo.2014.00195","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6853_CR198","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","volume":"6","author":"E Ahlqvist","year":"2018","unstructured":"Ahlqvist E, Storm P, K\u00e4r\u00e4j\u00e4m\u00e4ki A et al (2018) Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 6:361\u2013369. https:\/\/doi.org\/10.1016\/S2213-8587(18)30051-2","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"Suppl. 2","key":"6853_CR199","doi-asserted-by":"publisher","first-page":"S262","DOI":"10.2337\/dc08-s264","volume":"31","author":"MH Shanik","year":"2008","unstructured":"Shanik MH, Xu Y, Skrha J, Dankner R, Zick Y, Roth J (2008) Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care 31(Suppl. 2):S262\u2013S268. https:\/\/doi.org\/10.2337\/dc08-s264","journal-title":"Diabetes Care"},{"key":"6853_CR200","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2337\/db11-1483","volume":"61","author":"BE Corkey","year":"2012","unstructured":"Corkey BE (2012) Banting Lecture 2011: hyperinsulinemia: cause or consequence? Diabetes 61:4\u201313. https:\/\/doi.org\/10.2337\/db11-1483","journal-title":"Diabetes"},{"key":"6853_CR201","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2337\/dbi23-0035","volume":"73","author":"B Mittendorfer","year":"2024","unstructured":"Mittendorfer B, Johnson JD, Solinas G, Jansson P-A (2024) Insulin hypersecretion as promoter of body fat gain and hyperglycemia. Diabetes 73:837\u2013843. https:\/\/doi.org\/10.2337\/dbi23-0035","journal-title":"Diabetes"},{"key":"6853_CR202","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1046\/j.1464-5491.2002.00794.x","volume":"19","author":"E Ferrannini","year":"2002","unstructured":"Ferrannini E, Balkau B (2002) Insulin: in search of a syndrome. Diabet Med 19:724\u2013729. https:\/\/doi.org\/10.1046\/j.1464-5491.2002.00794.x","journal-title":"Diabet Med"},{"key":"6853_CR203","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2337\/db23-0450","volume":"73","author":"D Tric\u00f2","year":"2024","unstructured":"Tric\u00f2 D, Chiriac\u00f2 M, Nouws J et al (2024) Alterations in adipose tissue distribution, cell morphology, and function mark primary insulin hypersecretion in youth with obesity. Diabetes 73:941\u2013952. https:\/\/doi.org\/10.2337\/db23-0450","journal-title":"Diabetes"},{"key":"6853_CR204","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.2337\/diabetes.50.6.1449","volume":"50","author":"PN B\u00e5venholm","year":"2001","unstructured":"B\u00e5venholm PN, Pigon J, Ostenson CG, Efendic S (2001) Insulin sensitivity of suppression of endogenous glucose production is the single most important determinant of glucose tolerance. Diabetes 50:1449\u20131454. https:\/\/doi.org\/10.2337\/diabetes.50.6.1449","journal-title":"Diabetes"},{"key":"6853_CR205","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.diabres.2008.09.052","volume":"83","author":"LM Sparks","year":"2009","unstructured":"Sparks LM, Ukropcova B, Smith J et al (2009) Relation of adipose tissue to metabolic flexibility. Diabetes Res Clin Pract 83:32\u201343. https:\/\/doi.org\/10.1016\/j.diabres.2008.09.052","journal-title":"Diabetes Res Clin Pract"},{"key":"6853_CR206","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.2337\/diabetes.54.6.1640","volume":"54","author":"R Belfort","year":"2005","unstructured":"Belfort R, Mandarino L, Kashyap S et al (2005) Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 54:1640\u20131648. https:\/\/doi.org\/10.2337\/diabetes.54.6.1640","journal-title":"Diabetes"},{"key":"6853_CR207","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1475-2840-8-44","volume":"8","author":"Y Miyazaki","year":"2009","unstructured":"Miyazaki Y, DeFronzo RA (2009) Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type. Cardiovasc Diabetol 8:44. https:\/\/doi.org\/10.1186\/1475-2840-8-44","journal-title":"Cardiovasc Diabetol"},{"key":"6853_CR208","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nrendo.2011.138","volume":"8","author":"J Szendroedi","year":"2011","unstructured":"Szendroedi J, Phielix E, Roden M (2011) The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 8:92\u2013103. https:\/\/doi.org\/10.1038\/nrendo.2011.138","journal-title":"Nat Rev Endocrinol"},{"key":"6853_CR209","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","volume":"2","author":"R Azziz","year":"2016","unstructured":"Azziz R, Carmina E, Chen Z et al (2016) Polycystic ovary syndrome. Nat Rev Dis Primers 2:16057. https:\/\/doi.org\/10.1038\/nrdp.2016.57","journal-title":"Nat Rev Dis Primers"},{"key":"6853_CR210","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41574-024-01057-w","volume":"21","author":"N Helvaci","year":"2025","unstructured":"Helvaci N, Yildiz BO (2025) Polycystic ovary syndrome as a metabolic disease. Nat Rev Endocrinol 21:230\u2013244. https:\/\/doi.org\/10.1038\/s41574-024-01057-w","journal-title":"Nat Rev Endocrinol"},{"key":"6853_CR211","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/JOE-15-0533","volume":"229","author":"ME Cleasby","year":"2016","unstructured":"Cleasby ME, Jamieson PM, Atherton PJ (2016) Insulin resistance and sarcopenia: mechanistic links between common co-morbidities. J Endocrinol 229:R67\u2013R81. https:\/\/doi.org\/10.1530\/JOE-15-0533","journal-title":"J Endocrinol"},{"key":"6853_CR212","doi-asserted-by":"publisher","first-page":"285","DOI":"10.4093\/dmj.2020.0250","volume":"45","author":"AMY Zhang","year":"2021","unstructured":"Zhang AMY, Wellberg EA, Kopp JL, Johnson JD (2021) Hyperinsulinemia in obesity, inflammation, and cancer. Diabetes Metab J 45:285\u2013311. https:\/\/doi.org\/10.4093\/dmj.2020.0250","journal-title":"Diabetes Metab J"},{"key":"6853_CR213","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41568-020-0295-5","volume":"20","author":"EJ Gallagher","year":"2020","unstructured":"Gallagher EJ, LeRoith D (2020) Hyperinsulinaemia in cancer. Nat Rev Cancer 20:629\u2013644. https:\/\/doi.org\/10.1038\/s41568-020-0295-5","journal-title":"Nat Rev Cancer"},{"key":"6853_CR214","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0030-1267203","volume":"43","author":"TP Ciaraldi","year":"2011","unstructured":"Ciaraldi TP, Sasaoka T (2011) Review on the in vitro interaction of insulin glargine with the insulin\/insulin-like growth factor system: potential implications for metabolic and mitogenic activities. Horm Metab Res 43:1\u201310. https:\/\/doi.org\/10.1055\/s-0030-1267203","journal-title":"Horm Metab Res"},{"key":"6853_CR215","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1758-5996-3-10","volume":"3","author":"B Draznin","year":"2011","unstructured":"Draznin B (2011) Mechanism of the mitogenic influence of hyperinsulinemia. Diabetol Metab Syndr 3:10. https:\/\/doi.org\/10.1186\/1758-5996-3-10","journal-title":"Diabetol Metab Syndr"},{"key":"6853_CR216","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11892-008-0040-z","volume":"8","author":"S Muntoni","year":"2008","unstructured":"Muntoni S, Muntoni S, Draznin B (2008) Effects of chronic hyperinsulinemia in insulin-resistant patients. Curr Diab Rep 8:233\u2013238. https:\/\/doi.org\/10.1007\/s11892-008-0040-z","journal-title":"Curr Diab Rep"},{"key":"6853_CR217","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.str.2015.12.014","volume":"24","author":"TI Croll","year":"2016","unstructured":"Croll TI, Smither BJ, Margetts MB et al (2016) Higher-resolution structure of the human insulin receptor ectodomain: multi-modal inclusion of the insert domain. Structure 24:469\u2013476. https:\/\/doi.org\/10.1016\/j.str.2015.12.014","journal-title":"Structure"},{"key":"6853_CR218","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nature11781","volume":"493","author":"JG Menting","year":"2013","unstructured":"Menting JG, Whittaker J, Margetts MB et al (2013) How insulin engages its primary binding site on the insulin receptor. Nature 493:241\u2013245. https:\/\/doi.org\/10.1038\/nature11781","journal-title":"Nature"},{"key":"6853_CR219","doi-asserted-by":"publisher","first-page":"e48630","DOI":"10.7554\/eLife.48630","volume":"8","author":"E Uchikawa","year":"2019","unstructured":"Uchikawa E, Choi E, Shang G, Yu H, Bai X-C (2019) Activation mechanism of the insulin receptor revealed by cryo-EM structure of the fully liganded receptor-ligand complex. Elife 8:e48630. https:\/\/doi.org\/10.7554\/eLife.48630","journal-title":"Elife"},{"key":"6853_CR220","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nature26153","volume":"556","author":"G Scapin","year":"2018","unstructured":"Scapin G, Dandey VP, Zhang Z et al (2018) Structure of the insulin receptor-insulin complex by single-particle cryo-EM analysis. Nature 556:122\u2013125. https:\/\/doi.org\/10.1038\/nature26153","journal-title":"Nature"},{"key":"6853_CR221","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41594-022-00750-6","volume":"29","author":"J Li","year":"2022","unstructured":"Li J, Park J, Mayer JP et al (2022) Synergistic activation of the insulin receptor via two distinct sites. Nat Struct Mol Biol 29:357\u2013368. https:\/\/doi.org\/10.1038\/s41594-022-00750-6","journal-title":"Nat Struct Mol Biol"},{"key":"6853_CR222","doi-asserted-by":"publisher","first-page":"167458","DOI":"10.1016\/j.jmb.2022.167458","volume":"434","author":"J Nielsen","year":"2022","unstructured":"Nielsen J, Brandt J, Boesen T et al (2022) Structural investigations of full-length insulin receptor dynamics and signalling. J Mol Biol 434:167458. https:\/\/doi.org\/10.1016\/j.jmb.2022.167458","journal-title":"J Mol Biol"},{"key":"6853_CR223","doi-asserted-by":"publisher","first-page":"e201907210","DOI":"10.1083\/jcb.201907210","volume":"219","author":"T Gutmann","year":"2020","unstructured":"Gutmann T, Sch\u00e4fer IB, Poojari C (2020) Cryo-EM structure of the complete and ligand-saturated insulin receptor ectodomain. J Cell Biol 219:e201907210. https:\/\/doi.org\/10.1083\/jcb.201907210","journal-title":"J Cell Biol"},{"key":"6853_CR224","doi-asserted-by":"publisher","first-page":"101304","DOI":"10.1016\/j.molmet.2021.101304","volume":"52","author":"MF White","year":"2021","unstructured":"White MF, Kahn CR (2021) Insulin action at a molecular level: 100 years of progress. Mol Metab 52:101304. https:\/\/doi.org\/10.1016\/j.molmet.2021.101304","journal-title":"Mol Metab"},{"key":"6853_CR225","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20120769","volume":"447","author":"MKB Wills","year":"2012","unstructured":"Wills MKB, Jones N (2012) Teaching an old dogma new tricks: twenty years of Shc adaptor signalling. Biochem J 447:1\u201316. https:\/\/doi.org\/10.1042\/BJ20120769","journal-title":"Biochem J"},{"key":"6853_CR226","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1083\/jcb.200503088","volume":"170","author":"J Luo","year":"2005","unstructured":"Luo J, Field SJ, Lee JY, Engelman JA, Cantley LC (2005) The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex. J Cell Biol 170:455\u2013464. https:\/\/doi.org\/10.1083\/jcb.200503088","journal-title":"J Cell Biol"},{"key":"6853_CR227","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1371\/journal.pbio.0050095","volume":"5","author":"V Calleja","year":"2007","unstructured":"Calleja V, Alcor D, Laguerre M et al (2007) Intramolecular and intermolecular interactions of protein kinase B define its activation in vivo. PLoS Biol 5:e95. https:\/\/doi.org\/10.1371\/journal.pbio.0050095","journal-title":"PLoS Biol"},{"key":"6853_CR228","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1126\/science.1106148","volume":"307","author":"DD Sarbassov","year":"2005","unstructured":"Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005) Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex. Science 307:1098\u20131101. https:\/\/doi.org\/10.1126\/science.1106148","journal-title":"Science"},{"key":"6853_CR229","doi-asserted-by":"publisher","first-page":"6541","DOI":"10.1002\/j.1460-2075.1996.tb01045.x","volume":"15","author":"DR Alessi","year":"1996","unstructured":"Alessi DR, Andjelkovic M, Caudwell B et al (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15:6541\u20136551. https:\/\/doi.org\/10.1002\/j.1460-2075.1996.tb01045.x","journal-title":"EMBO J"},{"key":"6853_CR230","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1128\/MCB.00422-15","volume":"35","author":"LM DiPilato","year":"2015","unstructured":"DiPilato LM, Ahmad F, Harms M, Seale P, Manganiello V, Birnbaum MJ (2015) The role of PDE3B phosphorylation in the inhibition of lipolysis by insulin. Mol Cell Biol 35:2752\u20132760. https:\/\/doi.org\/10.1128\/MCB.00422-15","journal-title":"Mol Cell Biol"},{"key":"6853_CR231","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.cmet.2013.04.010","volume":"17","author":"SJ Humphrey","year":"2013","unstructured":"Humphrey SJ, Yang G, Yang P et al (2013) Dynamic adipocyte phosphoproteome reveals that Akt directly regulates mTORC2. Cell Metab 17:1009\u20131020. https:\/\/doi.org\/10.1016\/j.cmet.2013.04.010","journal-title":"Cell Metab"},{"key":"6853_CR232","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1038\/s42255-025-01349-z","volume":"7","author":"JG Burchfield","year":"2025","unstructured":"Burchfield JG, Diaz-Vegas A, James DE (2025) The insulin signalling network. Nat Metab 7:1745\u20131764. https:\/\/doi.org\/10.1038\/s42255-025-01349-z","journal-title":"Nat Metab"},{"key":"6853_CR233","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrm.2017.89","volume":"19","author":"RA Haeusler","year":"2018","unstructured":"Haeusler RA, McGraw TE, Accili D (2018) Biochemical and cellular properties of insulin receptor signalling. Nat Rev Mol Cell Biol 19:31\u201344. https:\/\/doi.org\/10.1038\/nrm.2017.89","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6853_CR234","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41580-025-00826-3","volume":"26","author":"E Choi","year":"2025","unstructured":"Choi E, Duan C, Bai X-C (2025) Regulation and function of insulin and insulin-like growth factor receptor signalling. Nat Rev Mol Cell Biol 26:558\u2013580. https:\/\/doi.org\/10.1038\/s41580-025-00826-3","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6853_CR235","doi-asserted-by":"publisher","first-page":"22115","DOI":"10.1074\/jbc.C200198200","volume":"277","author":"S Kane","year":"2002","unstructured":"Kane S, Sano H, Liu SCH et al (2002) A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain. J Biol Chem 277:22115\u201322118. https:\/\/doi.org\/10.1074\/jbc.C200198200","journal-title":"J Biol Chem"},{"key":"6853_CR236","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1042\/BJ20061798","volume":"403","author":"WG Roach","year":"2007","unstructured":"Roach WG, Chavez JA, M\u00eeinea CP, Lienhard GE (2007) Substrate specificity and effect on GLUT4 translocation of the Rab GTPase-activating protein Tbc1d1. Biochem J 403:353\u2013358. https:\/\/doi.org\/10.1042\/BJ20061798","journal-title":"Biochem J"},{"key":"6853_CR237","doi-asserted-by":"publisher","first-page":"4484","DOI":"10.1091\/mbc.e06-07-0585","volume":"17","author":"E Gonzalez","year":"2006","unstructured":"Gonzalez E, McGraw TE (2006) Insulin signaling diverges into Akt-dependent and -independent signals to regulate the recruitment\/docking and the fusion of GLUT4 vesicles to the plasma membrane. Mol Biol Cell 17:4484\u20134493. https:\/\/doi.org\/10.1091\/mbc.e06-07-0585","journal-title":"Mol Biol Cell"},{"key":"6853_CR238","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.2337\/db12-1148","volume":"62","author":"L Sylow","year":"2013","unstructured":"Sylow L, Jensen TE, Kleinert M et al (2013) Rac1 signaling is required for insulin-stimulated glucose uptake and is dysregulated in insulin-resistant murine and human skeletal muscle. Diabetes 62:1865\u20131875. https:\/\/doi.org\/10.2337\/db12-1148","journal-title":"Diabetes"},{"key":"6853_CR239","doi-asserted-by":"publisher","first-page":"43229","DOI":"10.1074\/jbc.M111.306621","volume":"286","author":"D Balamatsias","year":"2011","unstructured":"Balamatsias D, Kong AM, Waters JE et al (2011) Identification of P-Rex1 as a novel Rac1-guanine nucleotide exchange factor (GEF) that promotes actin remodeling and GLUT4 protein trafficking in adipocytes. J Biol Chem 286:43229\u201343240. https:\/\/doi.org\/10.1074\/jbc.M111.306621","journal-title":"J Biol Chem"},{"key":"6853_CR240","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.2337\/diabetes.54.6.1692","volume":"54","author":"HKR Karlsson","year":"2005","unstructured":"Karlsson HKR, Zierath JR, Kane S, Krook A, Lienhard GE, Wallberg-Henriksson H (2005) Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects. Diabetes 54:1692\u20131697. https:\/\/doi.org\/10.2337\/diabetes.54.6.1692","journal-title":"Diabetes"},{"key":"6853_CR241","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00125-010-1924-4","volume":"54","author":"BF Vind","year":"2011","unstructured":"Vind BF, Pehm\u00f8ller C, Treebak JT et al (2011) Impaired insulin-induced site-specific phosphorylation of TBC1 domain family, member 4 (TBC1D4) in skeletal muscle of type 2 diabetes patients is restored by endurance exercise-training. Diabetologia 54:157\u2013167. https:\/\/doi.org\/10.1007\/s00125-010-1924-4","journal-title":"Diabetologia"},{"key":"6853_CR242","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1038\/s42255-024-01153-1","volume":"6","author":"JM Kristensen","year":"2024","unstructured":"Kristensen JM, Kj\u00f8bsted R, Larsen TJ et al (2024) Skeletal muscle from TBC1D4 p.Arg684Ter variant carriers is severely insulin resistant but exhibits normal metabolic responses during exercise. Nat Metab 6:2254\u20132266. https:\/\/doi.org\/10.1038\/s42255-024-01153-1","journal-title":"Nat Metab"},{"key":"6853_CR243","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/nature13425","volume":"512","author":"I Moltke","year":"2014","unstructured":"Moltke I, Grarup N, J\u00f8rgensen ME et al (2014) A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes. Nature 512:190\u2013193. https:\/\/doi.org\/10.1038\/nature13425","journal-title":"Nature"},{"key":"6853_CR244","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/embor.2010.160","volume":"11","author":"H Gehart","year":"2010","unstructured":"Gehart H, Kumpf S, Ittner A, Ricci R (2010) MAPK signalling in cellular metabolism: stress or wellness? EMBO Rep 11:834\u2013840. https:\/\/doi.org\/10.1038\/embor.2010.160","journal-title":"EMBO Rep"},{"key":"6853_CR245","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0079-6107(98)00056-X","volume":"71","author":"MH Cobb","year":"1999","unstructured":"Cobb MH (1999) MAP kinase pathways. Prog Biophys Mol Biol 71:479\u2013500. https:\/\/doi.org\/10.1016\/S0079-6107(98)00056-X","journal-title":"Prog Biophys Mol Biol"},{"key":"6853_CR246","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.1016\/S0021-9258(18)53382-2","volume":"268","author":"GJ Pronk","year":"1993","unstructured":"Pronk GJ, McGlade J, Pelicci G, Pawson T, Bos JL (1993) Insulin-induced phosphorylation of the 46- and 52-kDa Shc proteins. J Biol Chem 268:5748\u20135753. https:\/\/doi.org\/10.1016\/S0021-9258(18)53382-2","journal-title":"J Biol Chem"},{"key":"6853_CR247","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41556-018-0169-1","volume":"20","author":"RJ Nichols","year":"2018","unstructured":"Nichols RJ, Haderk F, Stahlhut C et al (2018) RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers. Nat Cell Biol 20:1064\u20131073. https:\/\/doi.org\/10.1038\/s41556-018-0169-1","journal-title":"Nat Cell Biol"},{"key":"6853_CR248","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.mce.2013.05.021","volume":"375","author":"P Jiao","year":"2013","unstructured":"Jiao P, Feng B, Li Y, He Q, Xu H (2013) Hepatic ERK activity plays a role in energy metabolism. Mol Cell Endocrinol 375:157\u2013166. https:\/\/doi.org\/10.1016\/j.mce.2013.05.021","journal-title":"Mol Cell Endocrinol"},{"key":"6853_CR249","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11010-016-2878-8","volume":"426","author":"KC Nandipati","year":"2017","unstructured":"Nandipati KC, Subramanian S, Agrawal DK (2017) Protein kinases: mechanisms and downstream targets in inflammation-mediated obesity and insulin resistance. Mol Cell Biochem 426:27\u201345. https:\/\/doi.org\/10.1007\/s11010-016-2878-8","journal-title":"Mol Cell Biochem"},{"key":"6853_CR250","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.coph.2009.07.004","volume":"9","author":"J-F Tanti","year":"2009","unstructured":"Tanti J-F, Jager J (2009) Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation. Curr Opin Pharmacol 9:753\u2013762. https:\/\/doi.org\/10.1016\/j.coph.2009.07.004","journal-title":"Curr Opin Pharmacol"},{"key":"6853_CR251","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1007\/s00125-016-3991-7","volume":"59","author":"H-T Wu","year":"2016","unstructured":"Wu H-T, Ou H-Y, Hung H-C et al (2016) A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes. Diabetologia 59:1732\u20131742. https:\/\/doi.org\/10.1007\/s00125-016-3991-7","journal-title":"Diabetologia"},{"key":"6853_CR252","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s12276-020-0456-3","volume":"52","author":"C Hall","year":"2020","unstructured":"Hall C, Yu H, Choi E (2020) Insulin receptor endocytosis in the pathophysiology of insulin resistance. Exp Mol Med 52:911\u2013920. https:\/\/doi.org\/10.1038\/s12276-020-0456-3","journal-title":"Exp Mol Med"},{"key":"6853_CR253","doi-asserted-by":"publisher","first-page":"a016790","DOI":"10.1101\/cshperspect.a016790","volume":"5","author":"LM Traub","year":"2013","unstructured":"Traub LM, Bonifacino JS (2013) Cargo recognition in clathrin-mediated endocytosis. Cold Spring Harb Perspect Biol 5:a016790. https:\/\/doi.org\/10.1101\/cshperspect.a016790","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"6853_CR254","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrm.2017.132","volume":"19","author":"M Kaksonen","year":"2018","unstructured":"Kaksonen M, Roux A (2018) Mechanisms of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol 19:313\u2013326. https:\/\/doi.org\/10.1038\/nrm.2017.132","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6853_CR255","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1083\/jcb.201802095","volume":"217","author":"VL Tokarz","year":"2018","unstructured":"Tokarz VL, MacDonald PE, Klip A (2018) The cell biology of systemic insulin function. J Cell Biol 217:2273\u20132289. https:\/\/doi.org\/10.1083\/jcb.201802095","journal-title":"J Cell Biol"},{"key":"6853_CR256","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/tra.12645","volume":"20","author":"S Yazdani","year":"2019","unstructured":"Yazdani S, Jaldin-Fincati JR, Pereira RVS, Klip A (2019) Endothelial cell barriers: transport of molecules between blood and tissues. Traffic 20:390\u2013403. https:\/\/doi.org\/10.1111\/tra.12645","journal-title":"Traffic"},{"key":"6853_CR257","doi-asserted-by":"publisher","first-page":"806","DOI":"10.2337\/diab.37.6.806","volume":"37","author":"DA McClain","year":"1988","unstructured":"McClain DA, Olefsky JM (1988) Evidence for two independent pathways of insulin-receptor internalization in hepatocytes and hepatoma cells. Diabetes 37:806\u2013815. https:\/\/doi.org\/10.2337\/diab.37.6.806","journal-title":"Diabetes"},{"key":"6853_CR258","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.cell.2016.05.074","volume":"166","author":"E Choi","year":"2016","unstructured":"Choi E, Zhang X, Xing C, Yu H (2016) Mitotic checkpoint regulators control insulin signaling and metabolic homeostasis. Cell 166:567\u2013581. https:\/\/doi.org\/10.1016\/j.cell.2016.05.074","journal-title":"Cell"},{"key":"6853_CR259","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1152\/ajpendo.2002.282.1.E1","volume":"282","author":"PE Bickel","year":"2002","unstructured":"Bickel PE (2002) Lipid rafts and insulin signaling. Am J Physiol Endocrinol Metab 282:E1\u2013E10. https:\/\/doi.org\/10.1152\/ajpendo.2002.282.1.E1","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"6853_CR260","doi-asserted-by":"publisher","first-page":"E1151","DOI":"10.1152\/ajpendo.00324.2003","volume":"285","author":"AW Cohen","year":"2003","unstructured":"Cohen AW, Combs TP, Scherer PE, Lisanti MP (2003) Role of caveolin and caveolae in insulin signaling and diabetes. Am J Physiol Endocrinol Metab 285:E1151\u2013E1160. https:\/\/doi.org\/10.1152\/ajpendo.00324.2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"6853_CR261","doi-asserted-by":"publisher","first-page":"10784","DOI":"10.1074\/jbc.270.18.10784","volume":"270","author":"AP Bevan","year":"1995","unstructured":"Bevan AP, Burgess JW, Drake PG, Shaver A, Bergeron JJ, Posner BI (1995) Selective activation of the rat hepatic endosomal insulin receptor kinase. Role for the endosome in insulin signaling. J Biol Chem 270:10784\u201310791. https:\/\/doi.org\/10.1074\/jbc.270.18.10784","journal-title":"J Biol Chem"},{"key":"6853_CR262","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/B978-0-12-397925-4.00017-1","volume":"535","author":"BI Posner","year":"2014","unstructured":"Posner BI, Bergeron JJM (2014) Assessment of internalization and endosomal signaling: studies with insulin and EGF. Methods Enzymol 535:293\u2013307. https:\/\/doi.org\/10.1016\/B978-0-12-397925-4.00017-1","journal-title":"Methods Enzymol"},{"key":"6853_CR263","doi-asserted-by":"publisher","first-page":"25450","DOI":"10.1074\/jbc.273.39.25450","volume":"273","author":"AW Kao","year":"1998","unstructured":"Kao AW, Ceresa BP, Santeler SR, Pessin JE (1998) Expression of a dominant interfering dynamin mutant in 3T3L1 adipocytes inhibits GLUT4 endocytosis without affecting insulin signaling. J Biol Chem 273:25450\u201325457. https:\/\/doi.org\/10.1074\/jbc.273.39.25450","journal-title":"J Biol Chem"},{"key":"6853_CR264","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1172\/JCI37432","volume":"119","author":"RK Semple","year":"2009","unstructured":"Semple RK, Sleigh A, Murgatroyd PR et al (2009) Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J Clin Invest 119:315\u2013322. https:\/\/doi.org\/10.1172\/JCI37432","journal-title":"J Clin Invest"},{"key":"6853_CR265","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1126\/science.1096706","volume":"304","author":"S George","year":"2004","unstructured":"George S, Rochford JJ, Wolfrum C et al (2004) A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 304:1325\u20131328. https:\/\/doi.org\/10.1126\/science.1096706","journal-title":"Science"},{"key":"6853_CR266","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13073-015-0179-6","volume":"7","author":"M Eiden","year":"2015","unstructured":"Eiden M, Koulman A, Hatunic M et al (2015) Mechanistic insights revealed by lipid profiling in monogenic insulin resistance syndromes. Genome Med 7:63. https:\/\/doi.org\/10.1186\/s13073-015-0179-6","journal-title":"Genome Med"},{"key":"6853_CR267","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1111\/j.1464-5491.2011.03463.x","volume":"28","author":"VER Parker","year":"2011","unstructured":"Parker VER, Savage DB, O\u2019Rahilly S, Semple RK (2011) Mechanistic insights into insulin resistance in the genetic era. Diabet Med 28:1476\u20131486. https:\/\/doi.org\/10.1111\/j.1464-5491.2011.03463.x","journal-title":"Diabet Med"},{"key":"6853_CR268","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrg.2016.56","volume":"17","author":"J Flannick","year":"2016","unstructured":"Flannick J, Florez JC (2016) Type 2 diabetes: genetic data sharing to advance complex disease research. Nat Rev Genet 17:535\u2013549. https:\/\/doi.org\/10.1038\/nrg.2016.56","journal-title":"Nat Rev Genet"},{"key":"6853_CR269","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41588-022-01058-3","volume":"54","author":"A Mahajan","year":"2022","unstructured":"Mahajan A, Spracklen CN, Zhang W et al (2022) Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. Nat Genet 54:560\u2013572. https:\/\/doi.org\/10.1038\/s41588-022-01058-3","journal-title":"Nat Genet"},{"key":"6853_CR270","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng.3714","volume":"49","author":"LA Lotta","year":"2017","unstructured":"Lotta LA, Gulati P, Day FR (2017) Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance. Nat Genet 49:17\u201326. https:\/\/doi.org\/10.1038\/ng.3714","journal-title":"Nat Genet"},{"key":"6853_CR271","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ng.2385","volume":"44","author":"RA Scott","year":"2012","unstructured":"Scott RA, Lagou V, Welch RP et al (2012) Large-scale association analyses identify new loci influencing glycemic traits and provide insight into underlying biological pathways. Nat Genet 44:991\u20131005. https:\/\/doi.org\/10.1038\/ng.2385","journal-title":"Nat Genet"},{"key":"6853_CR272","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/ng.2274","volume":"44","author":"AK Manning","year":"2012","unstructured":"Manning AK, Hivert M-F, Scott RA et al (2012) A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet 44:659\u2013669. https:\/\/doi.org\/10.1038\/ng.2274","journal-title":"Nat Genet"},{"key":"6853_CR273","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nature13478","volume":"510","author":"RJ Perry","year":"2014","unstructured":"Perry RJ, Samuel VT, Petersen KF, Shulman GI (2014) The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature 510:84\u201391. https:\/\/doi.org\/10.1038\/nature13478","journal-title":"Nature"},{"key":"6853_CR274","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.cmet.2012.03.005","volume":"15","author":"FR Jornayvaz","year":"2012","unstructured":"Jornayvaz FR, Shulman GI (2012) Diacylglycerol activation of protein kinase C\u03b5 and hepatic insulin resistance. Cell Metab 15:574\u2013584. https:\/\/doi.org\/10.1016\/j.cmet.2012.03.005","journal-title":"Cell Metab"},{"key":"6853_CR275","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/joim.12887","volume":"285","author":"M Ryd\u00e9n","year":"2019","unstructured":"Ryd\u00e9n M, Petrus P, Andersson DP et al (2019) Insulin action is severely impaired in adipocytes of apparently healthy overweight and obese subjects. J Intern Med 285:578\u2013588. https:\/\/doi.org\/10.1111\/joim.12887","journal-title":"J Intern Med"},{"key":"6853_CR276","doi-asserted-by":"publisher","first-page":"eadi2689","DOI":"10.1126\/sciadv.adi2689","volume":"10","author":"AC Ludzki","year":"2024","unstructured":"Ludzki AC, Hansen M, Zareifi D et al (2024) Transcriptional determinants of lipid mobilization in human adipocytes. Sci Adv 10:eadi2689. https:\/\/doi.org\/10.1126\/sciadv.adi2689","journal-title":"Sci Adv"},{"key":"6853_CR277","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.bbadis.2008.10.019","volume":"1792","author":"S Fr\u00f6jd\u00f6","year":"2009","unstructured":"Fr\u00f6jd\u00f6 S, Vidal H, Pirola L (2009) Alterations of insulin signaling in type 2 diabetes: a review of the current evidence from humans. Biochim Biophys Acta 1792:83\u201392. https:\/\/doi.org\/10.1016\/j.bbadis.2008.10.019","journal-title":"Biochim Biophys Acta"},{"key":"6853_CR278","doi-asserted-by":"publisher","first-page":"36608","DOI":"10.1074\/jbc.M406499200","volume":"279","author":"S Stratford","year":"2004","unstructured":"Stratford S, Hoehn KL, Liu F, Summers SA (2004) Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt\/protein kinase B. J Biol Chem 279:36608\u201336615. https:\/\/doi.org\/10.1074\/jbc.M406499200","journal-title":"J Biol Chem"},{"key":"6853_CR279","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.1172\/JCI57144","volume":"121","author":"BT Bikman","year":"2011","unstructured":"Bikman BT, Summers SA (2011) Ceramides as modulators of cellular and whole-body metabolism. J Clin Invest 121:4222\u20134230. https:\/\/doi.org\/10.1172\/JCI57144","journal-title":"J Clin Invest"},{"key":"6853_CR280","doi-asserted-by":"publisher","first-page":"7794","DOI":"10.1128\/MCB.23.21.7794-7808.2003","volume":"23","author":"DJ Powell","year":"2003","unstructured":"Powell DJ, Hajduch E, Kular G, Hundal HS (2003) Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)\/Akt by a PKCzeta-dependent mechanism. Mol Cell Biol 23:7794\u20137808. https:\/\/doi.org\/10.1128\/MCB.23.21.7794-7808.2003","journal-title":"Mol Cell Biol"},{"key":"6853_CR281","doi-asserted-by":"publisher","first-page":"104815","DOI":"10.1016\/j.jbc.2023.104815","volume":"299","author":"CL Bandet","year":"2023","unstructured":"Bandet CL, Tan-Chen S, Ali-Berrada S et al (2023) Ceramide analog C2-cer induces a loss in insulin sensitivity in muscle cells through the salvage\/recycling pathway. J Biol Chem 299:104815. https:\/\/doi.org\/10.1016\/j.jbc.2023.104815","journal-title":"J Biol Chem"},{"key":"6853_CR282","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00125-021-05596-z","volume":"65","author":"T Sarabhai","year":"2022","unstructured":"Sarabhai T, Koliaki C, Mastrototaro L et al (2022) Dietary palmitate and oleate differently modulate insulin sensitivity in human skeletal muscle. Diabetologia 65:301\u2013314. https:\/\/doi.org\/10.1007\/s00125-021-05596-z","journal-title":"Diabetologia"},{"key":"6853_CR283","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.cmet.2012.04.002","volume":"15","author":"JA Chavez","year":"2012","unstructured":"Chavez JA, Summers SA (2012) A ceramide-centric view of insulin resistance. Cell Metab 15:585\u2013594. https:\/\/doi.org\/10.1016\/j.cmet.2012.04.002","journal-title":"Cell Metab"},{"key":"6853_CR284","doi-asserted-by":"publisher","first-page":"e001860","DOI":"10.1136\/bmjdrc-2020-001860","volume":"8","author":"M Apostolopoulou","year":"2020","unstructured":"Apostolopoulou M, Gordillo R, Gancheva S et al (2020) Role of ceramide-to-dihydroceramide ratios for insulin resistance and non-alcoholic fatty liver disease in humans. BMJ Open Diabetes Res Care 8:e001860. https:\/\/doi.org\/10.1136\/bmjdrc-2020-001860","journal-title":"BMJ Open Diabetes Res Care"},{"key":"6853_CR285","doi-asserted-by":"publisher","first-page":"100270","DOI":"10.1016\/j.jlr.2022.100270","volume":"63","author":"S Zarini","year":"2022","unstructured":"Zarini S, Brozinick JT, Zemski Berry KA et al (2022) Serum dihydroceramides correlate with insulin sensitivity in humans and decrease insulin sensitivity in vitro. J Lipid Res 63:100270. https:\/\/doi.org\/10.1016\/j.jlr.2022.100270","journal-title":"J Lipid Res"},{"key":"6853_CR286","doi-asserted-by":"publisher","first-page":"38052","DOI":"10.1074\/jbc.M106703200","volume":"276","author":"F Tremblay","year":"2001","unstructured":"Tremblay F, Marette A (2001) Amino acid and insulin signaling via the mTOR\/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. J Biol Chem 276:38052\u201338060. https:\/\/doi.org\/10.1074\/jbc.M106703200","journal-title":"J Biol Chem"},{"key":"6853_CR287","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","volume":"9","author":"CB Newgard","year":"2009","unstructured":"Newgard CB, An J, Bain JR et al (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9:311\u2013326. https:\/\/doi.org\/10.1016\/j.cmet.2009.02.002","journal-title":"Cell Metab"},{"key":"6853_CR288","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41580-021-00390-6","volume":"22","author":"DE James","year":"2021","unstructured":"James DE, St\u00f6ckli J, Birnbaum MJ (2021) The aetiology and molecular landscape of insulin resistance. Nat Rev Mol Cell Biol 22:751\u2013771. https:\/\/doi.org\/10.1038\/s41580-021-00390-6","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6853_CR289","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molmet.2019.08.001","volume":"28","author":"N Jaiswal","year":"2019","unstructured":"Jaiswal N, Gavin MG, Quinn WJ 3rd et al (2019) The role of skeletal muscle Akt in the regulation of muscle mass and glucose homeostasis. Mol Metab 28:1\u201313. https:\/\/doi.org\/10.1016\/j.molmet.2019.08.001","journal-title":"Mol Metab"},{"key":"6853_CR290","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nm.2686","volume":"18","author":"M Lu","year":"2012","unstructured":"Lu M, Wan M, Leavens KF et al (2012) Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nat Med 18:388\u2013395. https:\/\/doi.org\/10.1038\/nm.2686","journal-title":"Nat Med"},{"key":"6853_CR291","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1002\/oby.21528","volume":"24","author":"X Xie","year":"2016","unstructured":"Xie X, Yi Z, Sinha S et al (2016) Proteomics analyses of subcutaneous adipocytes reveal novel abnormalities in human insulin resistance. Obesity (Silver Spring) 24:1506\u20131514. https:\/\/doi.org\/10.1002\/oby.21528","journal-title":"Obesity (Silver Spring)"},{"key":"6853_CR292","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1007\/s00125-012-2644-8","volume":"55","author":"KD Copps","year":"2012","unstructured":"Copps KD, White MF (2012) Regulation of insulin sensitivity by serine\/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia 55:2565\u20132582. https:\/\/doi.org\/10.1007\/s00125-012-2644-8","journal-title":"Diabetologia"},{"key":"6853_CR293","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1128\/MCB.25.2.819-829.2005","volume":"25","author":"S Galic","year":"2005","unstructured":"Galic S, Hauser C, Kohn BB et al (2005) Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP. Mol Cell Biol 25:819\u2013829. https:\/\/doi.org\/10.1128\/MCB.25.2.819-829.2005","journal-title":"Mol Cell Biol"},{"key":"6853_CR294","doi-asserted-by":"publisher","first-page":"E581","DOI":"10.1152\/ajpendo.90437.2008","volume":"296","author":"S Boura-Halfon","year":"2009","unstructured":"Boura-Halfon S, Zick Y (2009) Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol Endocrinol Metab 296:E581\u2013E591. https:\/\/doi.org\/10.1152\/ajpendo.90437.2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"6853_CR295","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1089\/ars.2005.7.1021","volume":"7","author":"BJ Goldstein","year":"2005","unstructured":"Goldstein BJ, Mahadev K, Wu X, Zhu L, Motoshima H (2005) Role of insulin-induced reactive oxygen species in the insulin signaling pathway. Antioxid Redox Signal 7:1021\u20131031. https:\/\/doi.org\/10.1089\/ars.2005.7.1021","journal-title":"Antioxid Redox Signal"},{"key":"6853_CR296","doi-asserted-by":"publisher","unstructured":"DeFronzo RA, Tripathy D, Schwenke DC et al; ACT NOW Study (2013) Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlates. Diabetes 62:3920\u20133926. https:\/\/doi.org\/10.2337\/db13-0265","DOI":"10.2337\/db13-0265"},{"key":"6853_CR297","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/dom.14885","volume":"25","author":"AJ Moody","year":"2023","unstructured":"Moody AJ, Molina-Wilkins M, Clarke GD et al (2023) Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes. Diabetes Obes Metab 25:426\u2013434. https:\/\/doi.org\/10.1111\/dom.14885","journal-title":"Diabetes Obes Metab"},{"key":"6853_CR298","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.cmet.2014.08.005","volume":"20","author":"RE Soccio","year":"2014","unstructured":"Soccio RE, Chen ER, Lazar MA (2014) Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. Cell Metab 20:573\u2013591. https:\/\/doi.org\/10.1016\/j.cmet.2014.08.005","journal-title":"Cell Metab"},{"key":"6853_CR299","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nm.3159","volume":"19","author":"M Ahmadian","year":"2013","unstructured":"Ahmadian M, Suh JM, Hah N et al (2013) PPAR\u03b3 signaling and metabolism: the good, the bad and the future. Nat Med 19:557\u2013566. https:\/\/doi.org\/10.1038\/nm.3159","journal-title":"Nat Med"},{"key":"6853_CR300","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.2337\/dc05-2445","volume":"29","author":"A Gastaldelli","year":"2006","unstructured":"Gastaldelli A, Miyazaki Y, Mahankali A et al (2006) The effect of pioglitazone on the liver: role of adiponectin. Diabetes Care 29:2275\u20132281. https:\/\/doi.org\/10.2337\/dc05-2445","journal-title":"Diabetes Care"},{"key":"6853_CR301","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00125-007-0698-9","volume":"50","author":"M Bajaj","year":"2007","unstructured":"Bajaj M, Suraamornkul S, Hardies LJ, Glass L, Musi N, DeFronzo RA (2007) Effects of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus. Diabetologia 50:1723\u20131731. https:\/\/doi.org\/10.1007\/s00125-007-0698-9","journal-title":"Diabetologia"},{"key":"6853_CR302","doi-asserted-by":"publisher","first-page":"E225","DOI":"10.1152\/ajpendo.90960.2008","volume":"297","author":"A Gastaldelli","year":"2009","unstructured":"Gastaldelli A, Casolaro A, Ciociaro D et al (2009) Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients. Am J Physiol Endocrinol Metab 297:E225\u2013E230. https:\/\/doi.org\/10.1152\/ajpendo.90960.2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"6853_CR303","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1111\/liv.15005","volume":"41","author":"A Gastaldelli","year":"2021","unstructured":"Gastaldelli A, Sabatini S, Carli F et al (2021) PPAR-\u03b3-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH. Liver Int 41:2659\u20132670. https:\/\/doi.org\/10.1111\/liv.15005","journal-title":"Liver Int"},{"key":"6853_CR304","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1056\/NEJMra041001","volume":"351","author":"H Yki-J\u00e4rvinen","year":"2004","unstructured":"Yki-J\u00e4rvinen H (2004) Thiazolidinediones. N Engl J Med 351:1106\u20131118. https:\/\/doi.org\/10.1056\/NEJMra041001","journal-title":"N Engl J Med"},{"key":"6853_CR305","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.jhep.2024.12.045","volume":"82","author":"D Barb","year":"2025","unstructured":"Barb D, Kalavalapalli S, Godinez Leiva E et al (2025) Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD. J Hepatol 82:979\u2013991. https:\/\/doi.org\/10.1016\/j.jhep.2024.12.045","journal-title":"J Hepatol"},{"key":"6853_CR306","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s40618-026-02895-3","volume":"49","author":"RJ Galindo","year":"2026","unstructured":"Galindo RJ, Aronne LJ, Horn DB et al (2026) Reversion to normoglycemia with tirzepatide vs semaglutide in participants with obesity and prediabetes: a post hoc analysis of SURMOUNT-5. J Endocrinol Invest 49:1611\u20131620. https:\/\/doi.org\/10.1007\/s40618-026-02895-3","journal-title":"J Endocrinol Invest"},{"key":"6853_CR307","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1210\/clinem\/dgaa863","volume":"106","author":"MK Thomas","year":"2021","unstructured":"Thomas MK, Nikooienejad A, Bray R et al (2021) Dual GIP and GLP-1 receptor agonist tirzepatide improves beta-cell function and insulin sensitivity in type 2 diabetes. J Clin Endocrinol Metab 106:388\u2013396. https:\/\/doi.org\/10.1210\/clinem\/dgaa863","journal-title":"J Clin Endocrinol Metab"},{"key":"6853_CR308","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.2337\/dc25-1306","volume":"48","author":"C Caussy","year":"2025","unstructured":"Caussy C, Cusi K, Rosenstock J et al (2025) Relationship between metabolic and histological responses in people with metabolic dysfunction\u2013associated steatohepatitis with and without type 2 diabetes: participant-level exploratory analysis of the SYNERGY-NASH trial with tirzepatide. Diabetes Care 48:2074\u20132083. https:\/\/doi.org\/10.2337\/dc25-1306","journal-title":"Diabetes Care"},{"key":"6853_CR309","doi-asserted-by":"publisher","first-page":"e177625","DOI":"10.1172\/JCI177625","volume":"134","author":"RA DeFronzo","year":"2024","unstructured":"DeFronzo RA (2024) SGLT2 inhibitors: cardiorenal metabolic drugs for the ages. J Clin Invest 134:e177625. https:\/\/doi.org\/10.1172\/JCI177625","journal-title":"J Clin Invest"},{"key":"6853_CR310","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.2337\/db15-1356","volume":"65","author":"E Ferrannini","year":"2016","unstructured":"Ferrannini E, Baldi S, Frascerra S et al (2016) Shift to fatty substrate utilization in response to sodium\u2013glucose cotransporter 2 inhibition in subjects without diabetes and patients with type 2 diabetes. Diabetes 65:1190\u20131195. https:\/\/doi.org\/10.2337\/db15-1356","journal-title":"Diabetes"},{"key":"6853_CR311","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.2337\/dc15-2688","volume":"39","author":"G Daniele","year":"2016","unstructured":"Daniele G, Xiong J, Solis-Herrera C et al (2016) Dapagliflozin enhances fat oxidation and ketone production in patients with type 2 diabetes. Diabetes Care 39:2036\u20132041. https:\/\/doi.org\/10.2337\/dc15-2688","journal-title":"Diabetes Care"},{"key":"6853_CR312","doi-asserted-by":"publisher","first-page":"E258","DOI":"10.1152\/ajpendo.00267.2023","volume":"326","author":"LA Jahn","year":"2024","unstructured":"Jahn LA, Hartline LM, Nguyen T et al (2024) Empagliflozin improves vascular insulin sensitivity and muscle perfusion in persons with type 2 diabetes. Am J Physiol Endocrinol Metab 326:E258\u2013E267. https:\/\/doi.org\/10.1152\/ajpendo.00267.2023","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"6853_CR313","doi-asserted-by":"publisher","first-page":"398","DOI":"10.2337\/dc21-1136","volume":"45","author":"S Kullmann","year":"2022","unstructured":"Kullmann S, Hummel J, Wagner R et al (2022) Empagliflozin improves insulin densitivity of the hypothalamus in humans with prediabetes: a randomized, double-blind, placebo-controlled, phase 2 trial. Diabetes Care 45:398\u2013406. https:\/\/doi.org\/10.2337\/dc21-1136","journal-title":"Diabetes Care"},{"key":"6853_CR314","doi-asserted-by":"publisher","unstructured":"Rasouli N, Younes N, Ghosh A et al; GRADE Research Group (2024) Longitudinal effects of glucose-lowering medications on \u03b2-cell responses and insulin sensitivity in type 2 diabetes: the GRADE randomized clinical trial. Diabetes Care 47:580\u2013588. https:\/\/doi.org\/10.2337\/dc23-1070","DOI":"10.2337\/dc23-1070"},{"key":"6853_CR315","doi-asserted-by":"publisher","unstructured":"Kahn SE, Lachin JM, Zinman B et al; ADOPT Study Group (2011) Effects of rosiglitazone, glyburide, and metformin on \u03b2-cell function and insulin sensitivity in ADOPT. Diabetes 60:1552\u20131560. https:\/\/doi.org\/10.2337\/db10-1392","DOI":"10.2337\/db10-1392"},{"issue":"Suppl. 1","key":"6853_CR316","doi-asserted-by":"publisher","first-page":"S183","DOI":"10.2337\/dc26-S009","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes","year":"2026","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes (2026) 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes\u20142026. Diabetes Care 49(Suppl. 1):S183\u2013S215. https:\/\/doi.org\/10.2337\/dc26-S009","journal-title":"Diabetes Care"},{"key":"6853_CR317","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2337\/dci25-0054","volume":"49","author":"R Wagner","year":"2026","unstructured":"Wagner R, Selvin E, Sehgal R et al (2026) Beyond glucose: rethinking prediabetes for precision prevention. Diabetes Care 49:226\u2013235. https:\/\/doi.org\/10.2337\/dci25-0054","journal-title":"Diabetes Care"},{"key":"6853_CR318","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41591-020-1116-9","volume":"27","author":"R Wagner","year":"2021","unstructured":"Wagner R, Heni M, Tab\u00e1k AG et al (2021) Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes. Nat Med 27:49\u201357. https:\/\/doi.org\/10.1038\/s41591-020-1116-9","journal-title":"Nat Med"},{"key":"6853_CR319","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S2213-8587(19)30087-7","volume":"7","author":"JM Dennis","year":"2019","unstructured":"Dennis JM, Shields BM, Henley WE, Jones AG, Hattersley AT (2019) Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data. Lancet Diabetes Endocrinol 7:442\u2013451. https:\/\/doi.org\/10.1016\/S2213-8587(19)30087-7","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6853_CR320","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s00125-021-05567-4","volume":"65","author":"M Pigeyre","year":"2022","unstructured":"Pigeyre M, Hess S, Gomez MF et al (2022) Validation of the classification for type 2 diabetes into five subgroups: a report from the ORIGIN trial. Diabetologia 65:206\u2013215. https:\/\/doi.org\/10.1007\/s00125-021-05567-4","journal-title":"Diabetologia"},{"key":"6853_CR321","doi-asserted-by":"publisher","first-page":"637945","DOI":"10.3389\/fgene.2021.637945","volume":"12","author":"O Fedotkina","year":"2021","unstructured":"Fedotkina O, Sulaieva O, Ozgumus T et al (2021) Novel reclassification of adult diabetes is useful to distinguish stages of \u03b2-cell function linked to the risk of vascular complications: the DOLCE study from Northern Ukraine. Front Genet 12:637945. https:\/\/doi.org\/10.3389\/fgene.2021.637945","journal-title":"Front Genet"},{"key":"6853_CR322","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S2213-8587(25)00283-9","volume":"14","author":"O Asplund","year":"2026","unstructured":"Asplund O, Thangam M, Prasad RB et al (2026) Comorbidities and mortality in subgroups of adults with diabetes with up to 14 years follow-up: a prospective cohort study in Sweden. Lancet Diabetes Endocrinol 14:29\u201340. https:\/\/doi.org\/10.1016\/S2213-8587(25)00283-9","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6853_CR323","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12933-023-01923-3","volume":"22","author":"K Prystupa","year":"2023","unstructured":"Prystupa K, Delgado GE, Moissl AP et al (2023) Clusters of prediabetes and type 2 diabetes stratify all-cause mortality in a cohort of participants undergoing invasive coronary diagnostics. Cardiovasc Diabetol 22:211. https:\/\/doi.org\/10.1186\/s12933-023-01923-3","journal-title":"Cardiovasc Diabetol"},{"key":"6853_CR324","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12933-025-02660-5","volume":"24","author":"N Rohmann","year":"2025","unstructured":"Rohmann N, Epe J, Geisler C et al (2025) Comprehensive evaluation of diabetes subtypes in a European cohort reveals stronger differences of lifestyle, education and psychosocial parameters compared to metabolic or inflammatory factors. Cardiovasc Diabetol 24:99. https:\/\/doi.org\/10.1186\/s12933-025-02660-5","journal-title":"Cardiovasc Diabetol"},{"key":"6853_CR325","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/jdi.13707","volume":"13","author":"K Saito","year":"2022","unstructured":"Saito K, Inoue T, Ariyasu H et al (2022) Usefulness of subclassification of adult diabetes mellitus among inpatients in Japan. J Diabetes Investig 13:706\u2013713. https:\/\/doi.org\/10.1111\/jdi.13707","journal-title":"J Diabetes Investig"},{"key":"6853_CR326","doi-asserted-by":"publisher","first-page":"e3427","DOI":"10.1002\/dmrr.3427","volume":"37","author":"W Wang","year":"2021","unstructured":"Wang W, Pei X, Zhang L et al (2021) Application of new international classification of adult-onset diabetes in Chinese inpatients with diabetes mellitus. Diabetes Metab Res 37:e3427. https:\/\/doi.org\/10.1002\/dmrr.3427","journal-title":"Diabetes Metab Res"},{"key":"6853_CR327","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.3390\/jcm9072083","volume":"9","author":"H Tanabe","year":"2020","unstructured":"Tanabe H, Saito H, Kudo A et al (2020) Factors associated with risk of diabetic complications in novel cluster-based diabetes subgroups: a Japanese retrospective cohort study. J Clin Med 9:2083. https:\/\/doi.org\/10.3390\/jcm9072083","journal-title":"J Clin Med"},{"key":"6853_CR328","doi-asserted-by":"publisher","unstructured":"Wesolowska-Andersen A, Brorsson CA, Bizzotto R et al; IMI DIRECT Consortium (2022) Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: an IMI DIRECT study. Cell Rep Med 3:100477. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100477","DOI":"10.1016\/j.xcrm.2021.100477"},{"key":"6853_CR329","doi-asserted-by":"publisher","first-page":"e70137","DOI":"10.1111\/eci.70137","volume":"56","author":"AF Pina","year":"2026","unstructured":"Pina AF, Meneses MJ, Carli F et al (2026) Lipidomic profiling unveils sex differences in diabetes risk: implications for precision medicine. Eur J Clin Invest 56:e70137. https:\/\/doi.org\/10.1111\/eci.70137","journal-title":"Eur J Clin Invest"},{"key":"6853_CR330","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1038\/ki.2008.109","volume":"73","author":"T Tejada","year":"2008","unstructured":"Tejada T, Catanuto P, Ijaz A et al (2008) Failure to phosphorylate AKT in podocytes from mice with early diabetic nephropathy promotes cell death. Kidney Int 73:1385\u20131393. https:\/\/doi.org\/10.1038\/ki.2008.109","journal-title":"Kidney Int"},{"key":"6853_CR331","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cmet.2010.08.015","volume":"12","author":"GI Welsh","year":"2010","unstructured":"Welsh GI, Hale LJ, Eremina V et al (2010) Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab 12:329\u2013340. https:\/\/doi.org\/10.1016\/j.cmet.2010.08.015","journal-title":"Cell Metab"},{"key":"6853_CR332","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2337\/dc18-0344","volume":"41","author":"JM Dennis","year":"2018","unstructured":"Dennis JM, Henley WE, Weedon MN et al (2018) Sex and BMI alter the benefits and risks of sulfonylureas and thiazolidinediones in type 2 diabetes: a framework for evaluating stratification using routine clinical and individual trial data. Diabetes Care 41:1844\u20131853. https:\/\/doi.org\/10.2337\/dc18-0344","journal-title":"Diabetes Care"},{"key":"6853_CR333","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1007\/s00125-022-05769-4","volume":"65","author":"AJ Deutsch","year":"2022","unstructured":"Deutsch AJ, Ahlqvist E, Udler MS (2022) Phenotypic and genetic classification of diabetes. Diabetologia 65:1758\u20131769. https:\/\/doi.org\/10.1007\/s00125-022-05769-4","journal-title":"Diabetologia"},{"key":"6853_CR334","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.2337\/db20-1281","volume":"70","author":"RC Slieker","year":"2021","unstructured":"Slieker RC, Donnelly LA, Fitipaldi H (2021) Distinct molecular signatures of clinical clusters in people with type 2 diabetes: an IMI-RHAPSODY study. Diabetes 70:2683\u20132693. https:\/\/doi.org\/10.2337\/db20-1281","journal-title":"Diabetes"},{"key":"6853_CR335","doi-asserted-by":"publisher","first-page":"847611","DOI":"10.3389\/fendo.2022.847611","volume":"13","author":"D Zhen","year":"2022","unstructured":"Zhen D, Liu J, Zhang XD, Song Z (2022) Kynurenic acid acts as a signaling molecule regulating energy expenditure and is closely associated with metabolic diseases. Front Endocrinol (Lausanne) 13:847611. https:\/\/doi.org\/10.3389\/fendo.2022.847611","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6853_CR336","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1111\/dom.15786","volume":"26","author":"JA de Klerk","year":"2024","unstructured":"de Klerk JA, Beulens JWJ, Bijkerk R et al (2024) Circulating small non-coding RNAs are associated with the insulin-resistant and obesity-related type 2 diabetes clusters. Diabetes Obes Metab 26:4375\u20134385. https:\/\/doi.org\/10.1111\/dom.15786","journal-title":"Diabetes Obes Metab"},{"key":"6853_CR337","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3390\/ijms26020637","volume":"26","author":"F Sulaiman","year":"2025","unstructured":"Sulaiman F, Khyriem C, Dsouza S et al (2025) Characterizing circulating microRNA signatures of type 2 diabetes subtypes. Int J Mol Sci 26:637. https:\/\/doi.org\/10.3390\/ijms26020637","journal-title":"Int J Mol Sci"},{"key":"6853_CR338","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s00125-025-06600-6","volume":"69","author":"AG Maynard","year":"2026","unstructured":"Maynard AG, Bhardwaj R, Jones TR, Claussnitzer M (2026) Bridging the variant-to-function gap in type 2 diabetes: advances and challenges. Diabetologia 69:274\u2013294. https:\/\/doi.org\/10.1007\/s00125-025-06600-6","journal-title":"Diabetologia"},{"key":"6853_CR339","doi-asserted-by":"publisher","first-page":"100844","DOI":"10.1016\/j.xgen.2025.100844","volume":"5","author":"S Metz","year":"2025","unstructured":"Metz S, Belanich JR, Claussnitzer M, Kilpel\u00e4inen TO (2025) Variant-to-function approaches for adipose tissue: insights into cardiometabolic disorders. Cell Genom 5:100844. https:\/\/doi.org\/10.1016\/j.xgen.2025.100844","journal-title":"Cell Genom"},{"key":"6853_CR340","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1016\/j.molcel.2025.09.020","volume":"85","author":"X Wang","year":"2025","unstructured":"Wang X, Cardoso S, Cai K et al (2025) Tuning insulin receptor signaling using de novo-designed agonists. Mol Cell 85:4064-4081.e9. https:\/\/doi.org\/10.1016\/j.molcel.2025.09.020","journal-title":"Mol Cell"},{"key":"6853_CR341","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1007\/s00125-024-06248-8","volume":"67","author":"H Tanabe","year":"2024","unstructured":"Tanabe H, Sato M, Miyake A et al (2024) Machine learning-based reproducible prediction of type 2 diabetes subtypes. Diabetologia 67:2446\u20132458. https:\/\/doi.org\/10.1007\/s00125-024-06248-8","journal-title":"Diabetologia"},{"key":"6853_CR342","doi-asserted-by":"publisher","first-page":"eadv7834","DOI":"10.1126\/scitranslmed.adv7834","volume":"17","author":"S Kullmann","year":"2025","unstructured":"Kullmann S, Singh A, Sehgal R et al (2025) Circulating epigenetic signatures classifying brain insulin resistance in humans. Sci Transl Med 17:eadv7834. https:\/\/doi.org\/10.1126\/scitranslmed.adv7834","journal-title":"Sci Transl Med"},{"key":"6853_CR343","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1056\/NEJM199602293340906","volume":"334","author":"CJ Bailey","year":"1996","unstructured":"Bailey CJ, Turner RC (1996) Metformin. N Engl J Med 334:574\u2013579. https:\/\/doi.org\/10.1056\/NEJM199602293340906","journal-title":"N Engl J Med"},{"key":"6853_CR344","first-page":"98","volume":"6","author":"K Cusi","year":"1998","unstructured":"Cusi K, DeFronzo R (1998) Metformin: a review of its metabolic effects. Diabetes Rev 6:98\u2013131","journal-title":"Diabetes Rev"},{"key":"6853_CR345","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.3390\/ijms23031264","volume":"23","author":"R Herman","year":"2022","unstructured":"Herman R, Kravos NA, Jensterle M, Jane\u017e A, Dol\u017ean V (2022) Metformin and insulin resistance: a review of the underlying mechanisms behind changes in GLUT4-mediated glucose transport. Int J Mol Sci 23:1264. https:\/\/doi.org\/10.3390\/ijms23031264","journal-title":"Int J Mol Sci"},{"issue":"Suppl. 3","key":"6853_CR346","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.15663","volume":"26","author":"CJ Bailey","year":"2024","unstructured":"Bailey CJ (2024) Metformin: therapeutic profile in the treatment of type 2 diabetes. Diabetes Obes Metab 26(Suppl. 3):3\u201319. https:\/\/doi.org\/10.1111\/dom.15663","journal-title":"Diabetes Obes Metab"},{"key":"6853_CR347","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854\u2013865. https:\/\/doi.org\/10.1016\/S0140-6736(98)07037-8","journal-title":"Lancet"},{"key":"6853_CR348","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10557-008-6092-0","volume":"22","author":"CJ Bailey","year":"2008","unstructured":"Bailey CJ (2008) Metformin: effects on micro and macrovascular complications in type 2 diabetes. Cardiovasc Drugs Ther 22:215\u2013224. https:\/\/doi.org\/10.1007\/s10557-008-6092-0","journal-title":"Cardiovasc Drugs Ther"},{"key":"6853_CR349","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.2174\/0929867324666170404143102","volume":"24","author":"A Eisenreich","year":"2017","unstructured":"Eisenreich A, Leppert U (2017) Update on the protective renal effects of metformin in diabetic nephropathy. Curr Med Chem 24:3397\u20133412. https:\/\/doi.org\/10.2174\/0929867324666170404143102","journal-title":"Curr Med Chem"},{"key":"6853_CR350","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1001\/jamainternmed.2016.9607","volume":"177","author":"G Musso","year":"2017","unstructured":"Musso G, Cassader M, Paschetta E, Gambino R (2017) Thiazolidinediones and advanced liver fibrosis in nonalcoholic steatohepatitis: a meta-analysis. JAMA Intern Med 177:633\u2013640. https:\/\/doi.org\/10.1001\/jamainternmed.2016.9607","journal-title":"JAMA Intern Med"},{"key":"6853_CR351","doi-asserted-by":"publisher","first-page":"5389","DOI":"10.1038\/s41598-019-41854-2","volume":"9","author":"F Alam","year":"2019","unstructured":"Alam F, Islam MA, Mohamed M et al (2019) Efficacy and safety of pioglitazone monotherapy in type 2 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials. Sci Rep 9:5389. https:\/\/doi.org\/10.1038\/s41598-019-41854-2","journal-title":"Sci Rep"},{"key":"6853_CR352","doi-asserted-by":"publisher","first-page":"e013927","DOI":"10.1136\/bmjopen-2016-013927","volume":"7","author":"H-W Liao","year":"2017","unstructured":"Liao H-W, Saver JL, Wu Y-L, Chen T-H, Lee M, Ovbiagele B (2017) Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis. BMJ Open 7:e013927. https:\/\/doi.org\/10.1136\/bmjopen-2016-013927","journal-title":"BMJ Open"},{"key":"6853_CR353","doi-asserted-by":"publisher","first-page":"117090","DOI":"10.1016\/j.lfs.2019.117090","volume":"240","author":"H Yaribeygi","year":"2020","unstructured":"Yaribeygi H, Sathyapalan T, Maleki M, Jamialahmadi T, Sahebkar A (2020) Molecular mechanisms by which SGLT2 inhibitors can induce insulin sensitivity in diabetic milieu: a mechanistic review. Life Sci 240:117090. https:\/\/doi.org\/10.1016\/j.lfs.2019.117090","journal-title":"Life Sci"},{"key":"6853_CR354","doi-asserted-by":"publisher","first-page":"1174692","DOI":"10.3389\/fendo.2023.1174692","volume":"14","author":"CE Lam-Chung","year":"2023","unstructured":"Lam-Chung CE (2023) Comprehensive review of SGLT2 inhibitors\u2019 efficacy through their diuretic mode of action in diabetic patients. Front Endocrinol (Lausanne) 14:1174692. https:\/\/doi.org\/10.3389\/fendo.2023.1174692","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6853_CR355","unstructured":"US Food and Drug Administration (2013) Center for Drug Evaluation and Research application number 204042Orig1s000 summary. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2013\/204042orig1s000sumr.pdf. Accessed 19 March 2026"},{"key":"6853_CR356","unstructured":"US Food and Drug Administration (2014) Center for Drug Evaluation and Research application number 204629Orig1s000 pharmacology review(s). Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2014\/204629Orig1s000PharmR.pdf. Accessed 19 March 2026"},{"key":"6853_CR357","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","volume":"6","author":"DK McGuire","year":"2021","unstructured":"McGuire DK, Shih WJ, Cosentino F et al (2021) Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis. JAMA Cardiol 6:148\u2013158. https:\/\/doi.org\/10.1001\/jamacardio.2020.4511","journal-title":"JAMA Cardiol"},{"key":"6853_CR358","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1093\/ageing\/afz096","volume":"48","author":"P Monteiro","year":"2019","unstructured":"Monteiro P, Bergenstal RM, Toural E et al (2019) Efficacy and safety of empagliflozin in older patients in the EMPA-REG OUTCOME trial. Age Ageing 48:859\u2013866. https:\/\/doi.org\/10.1093\/ageing\/afz096","journal-title":"Age Ageing"},{"key":"6853_CR359","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2337\/diab.47.2.159","volume":"47","author":"DJ Drucker","year":"1998","unstructured":"Drucker DJ (1998) Glucagon-like peptides. Diabetes 47:159\u2013169. https:\/\/doi.org\/10.2337\/diab.47.2.159","journal-title":"Diabetes"},{"key":"6853_CR360","doi-asserted-by":"publisher","first-page":"101102","DOI":"10.1016\/j.molmet.2020.101102","volume":"46","author":"MA Nauck","year":"2021","unstructured":"Nauck MA, Quast DR, Wefers J, Meier JJ (2021) GLP-1 receptor agonists in the treatment of type 2 diabetes: state-of-the-art. Mol Metab 46:101102. https:\/\/doi.org\/10.1016\/j.molmet.2020.101102","journal-title":"Mol Metab"},{"key":"6853_CR361","doi-asserted-by":"publisher","first-page":"1431292","DOI":"10.3389\/fendo.2024.1431292","volume":"15","author":"QK Liu","year":"2024","unstructured":"Liu QK (2024) Mechanisms of action and therapeutic applications of GLP-1 and dual GIP\/GLP-1 receptor agonists. Front Endocrinol (Lausanne) 15:1431292. https:\/\/doi.org\/10.3389\/fendo.2024.1431292","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6853_CR362","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1007\/s12325-021-01710-0","volume":"38","author":"J Ard","year":"2021","unstructured":"Ard J, Fitch A, Fruh S, Herman L (2021) Weight loss and maintenance related to the mechanism of action of glucagon-like peptide 1 receptor agonists. Adv Ther 38:2821\u20132839. https:\/\/doi.org\/10.1007\/s12325-021-01710-0","journal-title":"Adv Ther"},{"key":"6853_CR363","doi-asserted-by":"publisher","first-page":"14514","DOI":"10.3390\/cimb46120872","volume":"46","author":"I Papakonstantinou","year":"2024","unstructured":"Papakonstantinou I, Tsioufis K, Katsi V (2024) Spotlight on the mechanism of action of semaglutide. Curr Issues Mol Biol 46:14514\u201314541. https:\/\/doi.org\/10.3390\/cimb46120872","journal-title":"Curr Issues Mol Biol"},{"key":"6853_CR364","doi-asserted-by":"publisher","first-page":"106320","DOI":"10.1016\/j.phrs.2022.106320","volume":"182","author":"G Bendotti","year":"2022","unstructured":"Bendotti G, Montefusco L, Lunati ME et al (2022) The anti-inflammatory and immunological properties of GLP-1 receptor agonists. Pharmacol Res 182:106320. https:\/\/doi.org\/10.1016\/j.phrs.2022.106320","journal-title":"Pharmacol Res"},{"key":"6853_CR365","doi-asserted-by":"publisher","first-page":"e3070","DOI":"10.1002\/dmrr.3070","volume":"35","author":"R Gentilella","year":"2019","unstructured":"Gentilella R, Pechtner V, Corcos A, Consoli A (2019) Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same? Diabetes Metab Res Rev 35:e3070. https:\/\/doi.org\/10.1002\/dmrr.3070","journal-title":"Diabetes Metab Res Rev"},{"key":"6853_CR366","doi-asserted-by":"publisher","unstructured":"Marso SP, Bain SC, Consoli A et al; SUSTAIN-6 Investigators (2016) Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 375:1834\u20131844. https:\/\/doi.org\/10.1056\/NEJMoa1607141","DOI":"10.1056\/NEJMoa1607141"},{"key":"6853_CR367","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1038\/s41591-024-03133-0","volume":"30","author":"JFE Mann","year":"2024","unstructured":"Mann JFE, Rossing P, Bakris G et al (2024) Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial. Nat Med 30:2849\u20132856. https:\/\/doi.org\/10.1038\/s41591-024-03133-0","journal-title":"Nat Med"},{"key":"6853_CR368","doi-asserted-by":"publisher","unstructured":"Sanyal AJ, Newsome PN, Kliers I et al; ESSENCE Study Group (2025) Phase 3 trial of semaglutide in metabolic dysfunction\u2013associated steatohepatitis. N Engl J Med 392:2089\u20132099. https:\/\/doi.org\/10.1056\/NEJMoa2413258","DOI":"10.1056\/NEJMoa2413258"},{"key":"6853_CR369","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.molmet.2018.09.009","volume":"18","author":"T Coskun","year":"2018","unstructured":"Coskun T, Sloop KW, Loghin C et al (2018) LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept. Mol Metab 18:3\u201314. https:\/\/doi.org\/10.1016\/j.molmet.2018.09.009","journal-title":"Mol Metab"},{"key":"6853_CR370","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.cmet.2024.05.010","volume":"36","author":"A Regmi","year":"2024","unstructured":"Regmi A, Aihara E, Christe ME et al (2024) Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor. Cell Metab 36:1534-1549.e7. https:\/\/doi.org\/10.1016\/j.cmet.2024.05.010","journal-title":"Cell Metab"},{"issue":"Suppl","key":"6853_CR371","doi-asserted-by":"publisher","first-page":"155457","DOI":"10.1016\/j.metabol.2023.155457","volume":"142","author":"D Finney","year":"2023","unstructured":"Finney D, Levine JA (2023) Efficacy and safety of tirzepatide in type 2 diabetes: the SURPASS clinical trial program. Metabolism 142(Suppl):155457. https:\/\/doi.org\/10.1016\/j.metabol.2023.155457","journal-title":"Metabolism"},{"key":"6853_CR372","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13098-023-01198-4","volume":"15","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Lei X, Fu S et al (2023) Efficacy and safety of tirzepatide, dual GLP-1\/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetol Metab Syndr 15:222. https:\/\/doi.org\/10.1186\/s13098-023-01198-4","journal-title":"Diabetol Metab Syndr"},{"key":"6853_CR373","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1016\/S0140-6736(18)32260-8","volume":"392","author":"JP Frias","year":"2018","unstructured":"Frias JP, Nauck MA, Van J et al (2018) Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial. Lancet 392:2180\u20132193. https:\/\/doi.org\/10.1016\/S0140-6736(18)32260-8","journal-title":"Lancet"},{"key":"6853_CR374","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3390\/ph14100991","volume":"14","author":"AS Bhagavathula","year":"2021","unstructured":"Bhagavathula AS, Vidyasagar K, Tesfaye W (2021) Efficacy and safety of tirzepatide in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized phase II\/III trials. Pharmaceuticals (Basel) 14:991. https:\/\/doi.org\/10.3390\/ph14100991","journal-title":"Pharmaceuticals (Basel)"},{"key":"6853_CR375","doi-asserted-by":"publisher","unstructured":"Packer M, Zile MR, Kramer CM et al; SUMMIT Trial Study Group (2025) Tirzepatide for heart failure with preserved ejection fraction and obesity. N Engl J Med 392:427\u2013437. https:\/\/doi.org\/10.1056\/NEJMoa2410027","DOI":"10.1056\/NEJMoa2410027"},{"key":"6853_CR376","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.jacc.2025.03.516","volume":"85","author":"A Aminorroaya","year":"2025","unstructured":"Aminorroaya A, Oikonomou EK, Biswas D, Jastreboff AM, Khera R (2025) Effects of tirzepatide in type 2 diabetes: individual variation and relationship to cardiometabolic outcomes. J Am Coll Cardiol 85:1858\u20131872. https:\/\/doi.org\/10.1016\/j.jacc.2025.03.516","journal-title":"J Am Coll Cardiol"},{"key":"6853_CR377","doi-asserted-by":"publisher","first-page":"e2427258","DOI":"10.1001\/jamanetworkopen.2024.27258","volume":"7","author":"M-H Chuang","year":"2024","unstructured":"Chuang M-H, Chen J-Y, Wang H-Y, Jiang Z-H, Wu V-C (2024) Clinical outcomes of tirzepatide or GLP-1 receptor agonists in individuals with type 2 diabetes. JAMA Netw Open 7:e2427258. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.27258","journal-title":"JAMA Netw Open"},{"key":"6853_CR378","doi-asserted-by":"publisher","unstructured":"Loomba R, Hartman ML, Lawitz EJ et al; SYNERGY-NASH Investigators (2024) Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis. N Engl J Med 391:299\u2013310. https:\/\/doi.org\/10.1056\/NEJMoa2401943","DOI":"10.1056\/NEJMoa2401943"},{"issue":"Suppl 2","key":"6853_CR379","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/s0026-0495(78)80007-9","volume":"27","author":"CR Kahn","year":"1978","unstructured":"Kahn CR (1978) Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism 27(Suppl 2):1893\u20131902. https:\/\/doi.org\/10.1016\/s0026-0495(78)80007-9","journal-title":"Metabolism"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06853-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-026-06853-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06853-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:01:59Z","timestamp":1790636519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-026-06853-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":379,"alternative-id":["6853"],"URL":"https:\/\/doi.org\/10.1007\/s00125-026-06853-9","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"29 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In addition to the manuscript authors, A. W. Ferrante Jr, of Columbia University, participated in the September 2025 Expert Forum and subsequent EASD symposium in Vienna, Austria. Editorial support services for this article were provided by D. Kendall of Kendall Editorial, Richmond, VA. Portions of the content were presented at a symposium at the EASD\u2019s 61st Annual Meeting on 17 September 2025 in Vienna, Austria.","order":1,"name":"Ethics","label":"Acknowledgements","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The 2025\n                      Diabetes\n                      ,\n                      Diabetes Care\n                      and\n                      Diabetologia\n                      Expert Forum \u2018Insulin Resistance in the 21st Century: New Takes on an Old Problem\u2019, including a subsequent symposium presented on this topic and the preparation of this article, was supported by a grant from the Novo Nordisk Foundation (NNF23SA0085453). AG has received funding from the European Union\u2019s Horizon Europe Research and Innovation Programme for the project \u2018PAS GRAS: De-risking Metabolic, Environmental and Behavioral Determinants of Obesity in Children, Adolescents and Young Adults\u2019 (grant agreement no. 101080329) and from the Italian Ministry of University and Research under the PRIN 2022 programme for the project \u2018BAGELS: Brain-body communicAtion: understandinG the rolE of peripheraL tissue metaboliSm and gut microbiota on brain function\u2019 (protocol no. 2022Y5LWBR_002; CUP B53C24007300006). EC has received funding from the Irma T. Hirschl Award and the Feldstein Medical Foundation. OG was supported by the Swedish Diabetes Foundation, the Swedish Research Council, Strategic Research Area Exodiab (grant agreement number 2009-1039) and the Swedish Foundation for Strategic Research (LUDC-IRC; grant agreement no. IRC15-0067). AK holds a Distinguished Investigator Grant within Endocrinology and Metabolism from the Novo Nordisk Foundation. SL has received funding from the Research Council of Finland (grant 365347). MR has received funding from the European Community (HORIZON-HLTH-2022-STAYHLTH-02-01: Panel A; INTERCEPT-T2D consortium) and German Research Foundation (DFG; CRC1774 CARDDIAB\/Cardio-Diabetes-Crosstalk, project A01). This work was supported in part by a European Research Council Consolidator Grant to MH (CrossPeriBrain, Project 101125605). Views and opinions expressed herein are the authors\u2019 alone and do not necessarily reflect those of the European Union or the European Research Council Executive Agency; neither the European Union nor the granting authority can be held responsible for them.","order":2,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"AG has received fees for speaking, consulting or participating on advisory boards for Boehringer Ingelheim, Eli Lilly, Madrigal, Merck-MSD, Novo Nordisk, Pfizer and Regeneron. KC-K is a former employee of Novo Nordisk. AK is the deputy editor-in-chief of\n                      Diabetologia\n                      . MR has received fees for consulting or lecturing from Astra Zeneca, Boehringer Ingelheim, Echosens, Eli Lilly, Madrigal, MSD, Novo Nordisk and Sanofi and has performed investigator-initiated research with support from Boehringer Ingelheim and Novo Nordisk. PS has received speaking fees or served on advisory boards for AstraZeneca, Medimmune, Rivus Pharmaceuticals and Unilever, has received support for investigator-initiated research from AstraZeneca, Medimmune, Pfizer and Unilever, is an associate editor of\n                      Diabetologia\n                      , and will begin serving as editor-in-chief of\n                      Diabetologia\n                      in 2027. MH has received lecture fees from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Chiesi, Lilly, Novartis, Novo Nordisk and Sanofi, has served on advisory boards for Boehringer Ingelheim, Chiesi and Lilly, and is a board member of the German Diabetes Association. The other authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":3,"name":"Ethics","label":"Authors\u2019 relationships and activities","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All authors contributed to writing and reviewing the manuscript. AG and MH revised the manuscript in response to peer reviewer comments, with additional revisions from EC, OG and AK on the section titled \u2018\n                      \n                      \u2019\n                      .\n                      All authors approved the final version. AG is the guarantor of this work and, as such, takes responsibility for the integrity of the review.","order":4,"name":"Ethics","label":"Contribution statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}